1
|
Chumin EJ, Cutts SA, Risacher SL, Apostolova LG, Farlow MR, McDonald BC, Wu YC, Betzel R, Saykin AJ, Sporns O. Edge time series components of functional connectivity and cognitive function in Alzheimer's disease. Brain Imaging Behav 2024; 18:243-255. [PMID: 38008852 PMCID: PMC10844434 DOI: 10.1007/s11682-023-00822-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/04/2023] [Indexed: 11/28/2023]
Abstract
Understanding the interrelationships of brain function as measured by resting-state magnetic resonance imaging and neuropsychological/behavioral measures in Alzheimer's disease is key for advancement of neuroimaging analysis methods in clinical research. The edge time-series framework recently developed in the field of network neuroscience, in combination with other network science methods, allows for investigations of brain-behavior relationships that are not possible with conventional functional connectivity methods. Data from the Indiana Alzheimer's Disease Research Center sample (53 cognitively normal control, 47 subjective cognitive decline, 32 mild cognitive impairment, and 20 Alzheimer's disease participants) were used to investigate relationships between functional connectivity components, each derived from a subset of time points based on co-fluctuation of regional signals, and measures of domain-specific neuropsychological functions. Multiple relationships were identified with the component approach that were not found with conventional functional connectivity. These involved attentional, limbic, frontoparietal, and default mode systems and their interactions, which were shown to couple with cognitive, executive, language, and attention neuropsychological domains. Additionally, overlapping results were obtained with two different statistical strategies (network contingency correlation analysis and network-based statistics correlation). Results demonstrate that connectivity components derived from edge time-series based on co-fluctuation reveal disease-relevant relationships not observed with conventional static functional connectivity.
Collapse
Affiliation(s)
- Evgeny J Chumin
- Department of Psychological and Brain Sciences, Indiana University (IU), Psychology Building 308, 1101 E 10th St, Bloomington, IN, 47405, USA.
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA.
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA.
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA.
| | - Sarah A Cutts
- Department of Psychological and Brain Sciences, Indiana University (IU), Psychology Building 308, 1101 E 10th St, Bloomington, IN, 47405, USA
- Program in Neuroscience, IU, Bloomington, IN, USA
| | - Shannon L Risacher
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
| | - Liana G Apostolova
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
- Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Martin R Farlow
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Brenna C McDonald
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
- Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Yu-Chien Wu
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
| | - Richard Betzel
- Department of Psychological and Brain Sciences, Indiana University (IU), Psychology Building 308, 1101 E 10th St, Bloomington, IN, 47405, USA
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Program in Neuroscience, IU, Bloomington, IN, USA
| | - Andrew J Saykin
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
- Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Olaf Sporns
- Department of Psychological and Brain Sciences, Indiana University (IU), Psychology Building 308, 1101 E 10th St, Bloomington, IN, 47405, USA
- Indiana University Network Sciences Institute, IU, Bloomington, IN, USA
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
- Indiana Alzheimer's Disease Research Center, IUSM, Indianapolis, IN, USA
- Program in Neuroscience, IU, Bloomington, IN, USA
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, USA
| |
Collapse
|
2
|
Hirschfeld LR, Deardorff R, Chumin EJ, Wu YC, McDonald BC, Cao S, Risacher SL, Yi D, Byun MS, Lee JY, Kim YK, Kang KM, Sohn CH, Nho K, Saykin AJ, Lee DY. White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum. Alzheimers Res Ther 2023; 15:218. [PMID: 38102714 PMCID: PMC10725037 DOI: 10.1186/s13195-023-01369-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Accepted: 12/07/2023] [Indexed: 12/17/2023]
Abstract
BACKGROUND White matter (WM) microstructural changes in the hippocampal cingulum bundle (CBH) in Alzheimer's disease (AD) have been described in cohorts of largely European ancestry but are lacking in other populations. METHODS We assessed the relationship between CBH WM integrity and cognition or amyloid burden in 505 Korean older adults aged ≥ 55 years, including 276 cognitively normal older adults (CN), 142 with mild cognitive impairment (MCI), and 87 AD patients, recruited as part of the Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's disease (KBASE) at Seoul National University. RESULTS Compared to CN, AD and MCI subjects showed significantly higher RD, MD, and AxD values (all p-values < 0.001) and significantly lower FA values (left p ≤ 0.002, right p ≤ 0.015) after Bonferroni adjustment for multiple comparisons. Most tests of cognition and mood (p < 0.001) as well as higher medial temporal amyloid burden (p < 0.001) were associated with poorer WM integrity in the CBH after Bonferroni adjustment. CONCLUSION These findings are consistent with patterns of WM microstructural damage previously reported in non-Hispanic White (NHW) MCI/AD cohorts, reinforcing existing evidence from predominantly NHW cohort studies.
Collapse
Affiliation(s)
- Lauren R Hirschfeld
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
| | - Rachael Deardorff
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Evgeny J Chumin
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, 47405, USA
| | - Yu-Chien Wu
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Brenna C McDonald
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Sha Cao
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Biostatistics and Health Data Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Shannon L Risacher
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Dahyun Yi
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, 03080, South Korea
| | - Min Soo Byun
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, South Korea
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, 03080, South Korea
| | - Jun-Young Lee
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, 03080, South Korea
- Department of Neuropsychiatry, SMG-SNU Boramae Medical Center, Seoul, 07061, South Korea
| | - Yu Kyeong Kim
- Department of Nuclear Medicine, SMG-SNU Boramae Medical Center, Seoul, 07061, South Korea
| | - Koung Mi Kang
- Department of Radiology, Seoul National University Hospital, Seoul, 03080, South Korea
| | - Chul-Ho Sohn
- Department of Radiology, Seoul National University Hospital, Seoul, 03080, South Korea
| | - Kwangsik Nho
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Indiana University School of Informatics and Computing, Indianapolis, IN, 46202, USA
| | - Andrew J Saykin
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
| | - Dong Young Lee
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, 03080, South Korea
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, South Korea
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, 03080, South Korea
| |
Collapse
|
3
|
Ge R, Yu Y, Qi YX, Fan YV, Chen S, Gao C, Haas SS, Modabbernia A, New F, Agartz I, Asherson P, Ayesa-Arriola R, Banaj N, Banaschewski T, Baumeister S, Bertolino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buckner R, Buitelaar JK, Cannon DM, Caseras X, Cervenka S, Conrod PJ, Crespo-Facorro B, Crivello F, Crone EA, de Haan L, de Zubicaray GI, Di Giorgio A, Erk S, Fisher SE, Franke B, Frodl T, Glahn DC, Grotegerd D, Gruber O, Gruner P, Gur RE, Gur RC, Harrison BJ, Hatton SN, Hickie I, Howells FM, Pol HEH, Huyser C, Jernigan TL, Jiang J, Joska JA, Kahn RS, Kalnin AJ, Kochan NA, Koops S, Kuntsi J, Lagopoulos J, Lazaro L, Lebedeva IS, Lochner C, Martin NG, Mazoyer B, McDonald BC, McDonald C, McMahon KL, Nakao T, Nyberg L, Piras F, Portella MJ, Qiu J, Roffman JL, Sachdev PS, Sanford N, Satterthwaite TD, Saykin AJ, Schumann G, Sellgren CM, Sim K, Smoller JW, Soares J, Sommer IE, Spalletta G, Stein DJ, Tamnes CK, Thomopolous SI, Tomyshev AS, Tordesillas-Gutiérrez D, Trollor JN, van ’t Ent D, van den Heuvel OA, van Erp TGM, van Haren NEM, Vecchio D, Veltman DJ, Walter H, Wang Y, Weber B, Wei D, Wen W, Westlye LT, Wierenga LM, Williams SCR, Wright MJ, Medland S, Wu MJ, Yu K, Jahanshad N, Thompson PM, Frangou S. Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization. bioRxiv 2023:2023.01.30.523509. [PMID: 38076938 PMCID: PMC10705253 DOI: 10.1101/2023.01.30.523509] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/22/2023]
Abstract
We present an empirically benchmarked framework for sex-specific normative modeling of brain morphometry that can inform about the biological and behavioral significance of deviations from typical age-related neuroanatomical changes and support future study designs. This framework was developed using regional morphometric data from 37,407 healthy individuals (53% female; aged 3-90 years) following a comparative evaluation of eight algorithms and multiple covariate combinations pertaining to image acquisition and quality, parcellation software versions, global neuroimaging measures, and longitudinal stability. The Multivariate Factorial Polynomial Regression (MFPR) emerged as the preferred algorithm optimized using nonlinear polynomials for age and linear effects of global measures as covariates. The MFPR models showed excellent accuracy across the lifespan and within distinct age-bins, and longitudinal stability over a 2-year period. The performance of all MFPR models plateaued at sample sizes exceeding 3,000 study participants. The model and scripts described here are freely available through CentileBrain (https://centilebrain.org/).
Collapse
Affiliation(s)
- Ruiyang Ge
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Yuetong Yu
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Yi Xuan Qi
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Yunan Vera Fan
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Shiyu Chen
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Chuntong Gao
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Shalaila S Haas
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Faye New
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Ingrid Agartz
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden
| | - Philip Asherson
- Institute of Psychiatry, Psychology and Neuroscience, Social, Genetic and Developmental Psychiatry Center, King's College London, London, UK
| | - Rosa Ayesa-Arriola
- Department of Psychiatry, Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain
| | - Nerisa Banaj
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
| | - Sarah Baumeister
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
| | - Alessandro Bertolino
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
| | - Dorret I Boomsma
- Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Stefan Borgwardt
- Translational Psychiatry Unit, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany
| | - Josiane Bourque
- Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Daniel Brandeis
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
- Department of Child and Adolescent Psychiatry, University of Zürich, Zurich, Switzerland
| | - Alan Breier
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Henry Brodaty
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Rachel M Brouwer
- Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Randy Buckner
- Department of Psychology, Center for Brain Science, Harvard University, Cambridge, Massachusetts, USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Jan K Buitelaar
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Dara M Cannon
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, Galway, Ireland
| | - Xavier Caseras
- MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Simon Cervenka
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden
- Department of Medical Sciences, Psychiatry, Uppsala University, Uppsala, Sweden
| | - Patricia J Conrod
- Department of Psychiatry and Addiction, Université de Montréal, CHU Ste Justine, Montréal, Canada
| | - Benedicto Crespo-Facorro
- University Hospital Virgen del Rocio, Seville, Spain; Department of Psychiatry, University of Seville, Institute of Biomedicine of Seville (IBIS), Seville, Spain
- Mental Health Research Networking Center (CIBERSAM), Madrid, Spain
| | - Fabrice Crivello
- Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France
| | - Eveline A Crone
- Department of Psychology, Education and Child Studies, Erasmus University Rotterdam, Rotterdam, The Netherlands
- Institute of Psychology, Leiden University, Leiden, The Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Liewe de Haan
- Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands
| | - Greig I de Zubicaray
- School of Psychology & Counselling, Faculty of Health, Queensland University of Technology, Brisbane, Australia
| | - Annabella Di Giorgio
- Laboratory of Biological Psychiatry, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
| | - Susanne Erk
- Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Simon E Fisher
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
- Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Thomas Frodl
- University Clinics and Clinics for Psychiatry, Psychotherapy and Psychosomatic Medicine, RWTH Aachen University, Aachen, Germany
| | - David C Glahn
- Department of Psychiatry, Tommy Fuss Center for Neuropsychiatric Disease Research Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Dominik Grotegerd
- Department of Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany
| | - Patricia Gruner
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
| | - Raquel E Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Ruben C Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Ben J Harrison
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Australia
| | - Sean N Hatton
- Center for Multimodal Imaging and Genetics, University of California San Diego, La jolla, California, USA
| | - Ian Hickie
- Brain and Mind Centre, University of Sydney, Sydney, Australia
| | - Fleur M Howells
- Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Hilleke E Hulshoff Pol
- Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- Department of Psychology, Utrecht University, Utrecht, The Netherlands
| | - Chaim Huyser
- Department of Child and Adolescent Psychiatry, Academic Medical Centre/De Bascule, Amsterdam, The Netherlands
| | - Terry L Jernigan
- Center for Human Development, Departments of Cognitive Science, Psychiatry, and Radiology, University of California, San Diego, USA
| | - Jiyang Jiang
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
| | - John A Joska
- Department of Neuropsychiatry, University of Cape Town, Cape Town, South Africa
| | - René S Kahn
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Andrew J Kalnin
- Department of Radiology, The Ohio State University College of Medicine, Columbus, Ohio, USA
| | - Nicole A Kochan
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Sanne Koops
- Department of Psychiatry and Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Jonna Kuntsi
- Institute of Psychiatry, Psychology and Neuroscience, Social, Genetic and Developmental Psychiatry Center, King's College London, London, UK
| | - Jim Lagopoulos
- Sunshine Coast Mind and Neuroscience - Thompson Institute, University of the Sunshine Coast, Queensland, Australia
| | - Luisa Lazaro
- Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic Barcelona, Barcelona, Spain
| | | | - Christine Lochner
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa
| | - Nicholas G Martin
- Queensland Institute of Medical Research, Berghofer Medical Research Institute, Brisbane, Australia
| | - Bernard Mazoyer
- Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Colm McDonald
- Centre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland
| | - Katie L McMahon
- School of Clinical Sciences, Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, Australia
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan
| | - Lars Nyberg
- Department of Radiation Sciences, Umeå Center for Functional Brain Imaging, Umeå University, Umeå, Sweden; Department of Integrative Medical Biology, Umeå University, Umeå, Sweden
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Maria J Portella
- Mental Health Research Networking Center (CIBERSAM), Madrid, Spain
- Department of Psychiatry, Hospital de la Santa Creu iSant Pau, Institutd' Investigació Biomèdica SantPau, Universitat Autònomade Barcelona (UAB), Barcelona, Spain
| | - Jiang Qiu
- Key Laboratory of Cognition and Personality, Southwest University, Ministry of Education, Chongqing, PR China
- Faculty of Psychology, Southwest University, Chongqing, PR China
- Southwest University Branch, Collaborative Innovation Center of Assessment Toward Basic Education Quality, Beijing Normal University, Beijing, PR China
| | - Joshua L Roffman
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Nicole Sanford
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | | | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Gunter Schumann
- Centre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology, and Neuroscience, Social, Genetic & Developmental Psychiatry Centre, King's College London, London, UK; Institute for Science and Technology of Brain-inspired Intelligence, Fudan University, Shanghai, PR China; Centre for Population Neuroscience and Stratified Medicine (PONS), Charite Mental Health, Department of Psychiatry and Psychotherapy, CCM, Charite Universitätsmedizin Berlin, Berlin, Germany
| | - Carl M Sellgren
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden
- Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
| | - Kang Sim
- Institute of Mental Health, Singapore
| | - Jordan W Smoller
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Jair Soares
- University of Texas Health Harris County Psychiatric Center, Houston, Texas, USA
| | - Iris E Sommer
- Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | | | - Dan J Stein
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Christian K Tamnes
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway
| | - Sophia I Thomopolous
- Genetics Center, Stevens Institute for Neuroimaging and Informatics, Keck USC School of Medicine, Marina del Rey, California, USA
| | | | - Diana Tordesillas-Gutiérrez
- Department of Radiology, Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain; Advanced Computing and e-Science, Instituto de Física de Cantabria (UC-CSIC), Santander, Spain
| | - Julian N Trollor
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
- Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Dennis van ’t Ent
- Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Odile A van den Heuvel
- Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands
- Department of Anatomy & Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Theo GM van Erp
- Department of Psychiatry and Human Behavior, University of California, Irvine, California, USA
| | - Neeltje EM van Haren
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Daniela Vecchio
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Dick J Veltman
- Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Henrik Walter
- Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Yang Wang
- Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
| | - Bernd Weber
- Institute for Experimental Epileptology and Cognition Research, University of Bonn Germany, Bonn, Germany; University Hospital Bonn, Bonn, Germany
| | - Dongtao Wei
- Key Laboratory of Cognition and Personality, Southwest University, Ministry of Education, Chongqing, PR China
- Faculty of Psychology, Southwest University, Chongqing, PR China
| | - Wei Wen
- Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Lars T Westlye
- Department of Psychology, University of Oslo, Oslo, Norway
| | - Lara M Wierenga
- Institute of Psychology, Leiden University, Leiden, The Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Steven CR Williams
- Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Margaret J Wright
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - Sarah Medland
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - Mon-Ju Wu
- Department of Psychiatry and Behavioral Science, University of Texas Health Science Center, Houston, Texas, USA
| | - Kevin Yu
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
| | - Neda Jahanshad
- Genetics Center, Stevens Institute for Neuroimaging and Informatics, Keck USC School of Medicine, Marina del Rey, California, USA
| | - Paul M Thompson
- Genetics Center, Stevens Institute for Neuroimaging and Informatics, Keck USC School of Medicine, Marina del Rey, California, USA
| | - Sophia Frangou
- Djavad Mowafagian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
4
|
Chumin EJ, Cutts SA, Risacher SL, Apostolova LG, Farlow MR, McDonald BC, Wu YC, Betzel R, Saykin AJ, Sporns O. Edge Time Series Components of Functional Connectivity and Cognitive Function in Alzheimer's Disease. medRxiv 2023:2023.05.13.23289936. [PMID: 38014005 PMCID: PMC10680898 DOI: 10.1101/2023.05.13.23289936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2023]
Abstract
Understanding the interrelationships of brain function as measured by resting-state magnetic resonance imaging and neuropsychological/behavioral measures in Alzheimer's disease is key for advancement of neuroimaging analysis methods in clinical research. The edge time-series framework recently developed in the field of network neuroscience, in combination with other network science methods, allows for investigations of brain-behavior relationships that are not possible with conventional functional connectivity methods. Data from the Indiana Alzheimer's Disease Research Center sample (53 cognitively normal control, 47 subjective cognitive decline, 32 mild cognitive impairment, and 20 Alzheimer's disease participants) were used to investigate relationships between functional connectivity components, each derived from a subset of time points based on co-fluctuation of regional signals, and measures of domain-specific neuropsychological functions. Multiple relationships were identified with the component approach that were not found with conventional functional connectivity. These involved attentional, limbic, frontoparietal, and default mode systems and their interactions, which were shown to couple with cognitive, executive, language, and attention neuropsychological domains. Additionally, overlapping results were obtained with two different statistical strategies (network contingency correlation analysis and network-based statistics correlation). Results demonstrate that connectivity components derived from edge time-series based on co-fluctuation reveal disease-relevant relationships not observed with conventional static functional connectivity.
Collapse
Affiliation(s)
- Evgeny J. Chumin
- Department of Psychological and Brain Sciences, Indiana University (IU), Bloomington, IN, United States
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
| | - Sarah A. Cutts
- Department of Psychological and Brain Sciences, Indiana University (IU), Bloomington, IN, United States
- Program in Neuroscience, IU, Bloomington, IN, United States
| | - Shannon L. Risacher
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
| | - Liana G. Apostolova
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
- Department of Neurology, IUSM, Indianapolis, IN, United States
| | - Martin R. Farlow
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Neurology, IUSM, Indianapolis, IN, United States
| | - Brenna C. McDonald
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
- Department of Neurology, IUSM, Indianapolis, IN, United States
| | - Yu-Chien Wu
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
| | - Richard Betzel
- Department of Psychological and Brain Sciences, Indiana University (IU), Bloomington, IN, United States
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Program in Neuroscience, IU, Bloomington, IN, United States
| | - Andrew J. Saykin
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
- Department of Neurology, IUSM, Indianapolis, IN, United States
| | - Olaf Sporns
- Department of Psychological and Brain Sciences, Indiana University (IU), Bloomington, IN, United States
- Indiana University Network Sciences Institute, IU, Bloomington, IN, United States
- Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM), Indianapolis, IN, United States
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, United States
- Program in Neuroscience, IU, Bloomington, IN, United States
- Department of Radiology and Imaging Sciences, IUSM, Indianapolis, IN, United States
| |
Collapse
|
5
|
Nakamura ZM, Small BJ, Zhai W, Ahles TA, Ahn J, Artese AL, Bethea TN, Breen EC, Cohen HJ, Extermann M, Graham D, Irwin MR, Isaacs C, Jim HSL, Kuhlman KR, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhou X, Mandelblatt JS, Carroll JE. Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study. J Cancer Surviv 2023:10.1007/s11764-023-01490-2. [PMID: 37924476 PMCID: PMC11068856 DOI: 10.1007/s11764-023-01490-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 10/21/2023] [Indexed: 11/06/2023]
Abstract
PURPOSE To identify trajectories of depressive symptoms in older breast cancer survivors and demographic, psychosocial, physical health, and cancer-related predictors of these trajectories. METHODS Recently diagnosed nonmetastatic breast cancer survivors (n = 272), ages 60-98 years, were evaluated for depressive symptoms (Center for Epidemiological Studies Depression Scale, CES-D; scores ≥16 suggestive of clinically significant depressive symptoms). CES-D scores were analyzed in growth-mixture models to determine depression trajectories from baseline (post-surgery, pre-systemic therapy) through 3-year annual follow-up. Multivariable, multinomial logistic regression was used to identify baseline predictors of depression trajectories. RESULTS Survivors had three distinct trajectories: stable (84.6%), emerging depressive symptoms (10.3%), and recovery from high depressive symptoms at baseline that improved slowly over time (5.1%). Compared to stable survivors, those in the emerging (OR = 1.16; 95% CI = 1.08-1.23) or recovery (OR = 1.26; 95% CI = 1.15-1.38) groups reported greater baseline anxiety. Greater baseline deficit accumulation (frailty composite measure) was associated with emerging depressive symptoms (OR = 3.71; 95% CI = 1.90-7.26). Less social support at baseline (OR = 0.38; 95% CI = 0.15-0.99), but greater improvement in emotional (F = 4.13; p = 0.0006) and tangible (F = 2.86; p = 0.01) social support over time, was associated with recovery from depressive symptoms. CONCLUSIONS Fifteen percent of older breast cancer survivors experienced emerging or recovery depressive symptom trajectories. Baseline anxiety, deficit accumulation, and lower social support were associated with worse outcomes. IMPLICATIONS FOR CANCER SURVIVORS Our results emphasize the importance of depression screening throughout the course of cancer care to facilitate early intervention. Factors associated with depressive symptoms, including lower levels of social support proximal to diagnosis, could serve as intervention levers.
Collapse
Affiliation(s)
- Zev M Nakamura
- Department of Psychiatry, University of North Carolina at Chapel Hill, 101 Manning Drive, Campus Box #7160, Chapel Hill, NC, 27599, USA.
| | - Brent J Small
- School of Aging Studies, University of South Florida, and Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Ashley L Artese
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA
| | - Traci N Bethea
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Elizabeth C Breen
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA
| | - Harvey J Cohen
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA
| | - Martine Extermann
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
| | - Deena Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
| | - Michael R Irwin
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA
| | - Claudine Isaacs
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Heather S L Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA
| | - Kate R Kuhlman
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Psychological Science, University of California, Irvine, CA, USA
- Institute for Interdisciplinary Salivary Bioscience Research, School of Social Ecology, University of California, Irvine, CA, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sunita K Patel
- City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - Kelly E Rentscher
- Department of Psychiatry and Behavioral Medicine, MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Danielle B Tometich
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA
| | - Kathleen Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Jeanne S Mandelblatt
- Georgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA
| | - Judith E Carroll
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA
| |
Collapse
|
6
|
Melis M, Blommaert J, Van der Gucht K, Smeets A, McDonald BC, Sunaert S, Smith A, Deprez S. The impact of mindfulness on working memory-related brain activation in breast cancer survivors with cognitive complaints. J Cancer Surviv 2023:10.1007/s11764-023-01484-0. [PMID: 37922071 DOI: 10.1007/s11764-023-01484-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Accepted: 10/11/2023] [Indexed: 11/05/2023]
Abstract
PURPOSE Cancer-related cognitive impairment (CRCI) has been associated with altered brain activation after chemotherapy in areas related to working memory. Hence, improving working memory capacity and associated brain activation might aid in the recovery of CRCI. In this study, we investigated the potential of a mindfulness-based intervention (MBI) to impact working memory-related brain activation. METHODS Female breast cancer survivors reporting cognitive complaints (N=117) were randomized into a mindfulness (n=43; MBI), physical training (n=36; PT), or waitlist control condition (n=38; WL). Participants completed MRI scans before the intervention, immediately after, and three months post-intervention. Task-based functional MRI was used to measure differences between groups over time in working memory-related brain activation while performing a visual-verbal n-back task. RESULTS Data of 83 participants (32/26/25 MBI/PT/WL) was included. Compared to the waitlist group, MBI participants showed reduced task-related activation in the right middle frontal and angular gyrus and increased activation in the right dorsal posterior cingulate cortex over time. Compared to the physical training group, MBI participants showed reduced brain activation in the bilateral superior parietal lobule and right dorsal anterior cingulate cortex over time. No differences between physical training and no intervention were identified. CONCLUSION This study showed that an 8-week mindfulness-based intervention can significantly alter brain activation across brain regions involved in working memory, attentional control, and emotion processing during performance of a working memory task. This might aid in the recovery of CRCI. IMPLICATIONS FOR CANCER SURVIVORS Mindfulness might alter brain activation patterns while performing a working memory task, which might ultimately aid in restoring higher order cognitive functions.
Collapse
Affiliation(s)
- Michelle Melis
- Department of Imaging and Pathology, Translational MRI, KU Leuven, Herestraat 49-box 7003, 3000, Leuven, UZ, Belgium.
- Research Foundation Flanders (FWO), Flanders, Belgium.
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
- Leuven Brain Institute, KU Leuven, Leuven, Belgium.
| | - Jeroen Blommaert
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium
- Leuven Brain Institute, KU Leuven, Leuven, Belgium
- Department of Oncology, KU Leuven, Leuven, Belgium
| | - Katleen Van der Gucht
- Leuven Mindfulness Centre, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium
- Department of Rehabilitation Sciences, Neuromodulation Laboratory, Biomedical Sciences Group, KU Leuven, Leuven, Belgium
- Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
| | - Ann Smeets
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium
- Department of Oncology, KU Leuven, Leuven, Belgium
- Multidisciplinary Breast Center, Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA
| | - Stefan Sunaert
- Department of Imaging and Pathology, Translational MRI, KU Leuven, Herestraat 49-box 7003, 3000, Leuven, UZ, Belgium
- Leuven Brain Institute, KU Leuven, Leuven, Belgium
- Department of Radiology, University Hospitals Leuven, Leuven, Belgium
| | - Andra Smith
- School of Psychology, University of Ottawa, Ottawa, Canada
| | - Sabine Deprez
- Department of Imaging and Pathology, Translational MRI, KU Leuven, Herestraat 49-box 7003, 3000, Leuven, UZ, Belgium
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium
- Leuven Brain Institute, KU Leuven, Leuven, Belgium
| |
Collapse
|
7
|
Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M, Wu YC, Gao S, McDonald BC, Yoder KK, Unverzagt FW, Wang S, Farlow MR, Brosch JR, Clark DG, Apostolova LG, Sims J, Wang DJ, Saykin AJ. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease. Neurobiol Aging 2023; 130:103-113. [PMID: 37499587 PMCID: PMC10529454 DOI: 10.1016/j.neurobiolaging.2023.06.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 05/30/2023] [Accepted: 06/21/2023] [Indexed: 07/29/2023]
Abstract
Identification of biomarkers for the early stages of Alzheimer's disease (AD) is an imperative step in developing effective treatments. Cerebral blood flow (CBF) is a potential early biomarker for AD; generally, older adults with AD have decreased CBF compared to normally aging peers. CBF deviates as the disease process and symptoms progress. However, further characterization of the relationships between CBF and AD risk factors and pathologies is still needed. We assessed the relationships between CBF quantified by arterial spin-labeled magnetic resonance imaging, hypertension, APOEε4, and tau and amyloid positron emission tomography in 77 older adults: cognitively normal, subjective cognitive decline, and mild cognitive impairment. Tau and amyloid aggregation were related to altered CBF, and some of these relationships were dependent on hypertension or APOEε4 status. Our findings suggest a complex relationship between risk factors, AD pathologies, and CBF that warrants future studies of CBF as a potential early biomarker for AD.
Collapse
Affiliation(s)
- Cecily G Swinford
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Shannon L Risacher
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Aaron Vosmeier
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Rachael Deardorff
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Evgeny J Chumin
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Indiana University Network Science Institute, Bloomington, IN, USA; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA
| | - Mario Dzemidzic
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Yu-Chien Wu
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Sujuan Gao
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Biostatistics and Health Data Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Karmen K Yoder
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA
| | - Frederick W Unverzagt
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sophia Wang
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Martin R Farlow
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Jared R Brosch
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - David G Clark
- Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Liana G Apostolova
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University Network Science Institute, Bloomington, IN, USA
| | - Justin Sims
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Danny J Wang
- Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University Network Science Institute, Bloomington, IN, USA.
| |
Collapse
|
8
|
de Ruiter MB, Deardorff RL, Blommaert J, Chen BT, Dumas JA, Schagen SB, Sunaert S, Wang L, Cimprich B, Peltier S, Dittus K, Newhouse PA, Silverman DH, Schroyen G, Deprez S, Saykin AJ, McDonald BC. Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis. Brain Imaging Behav 2023; 17:507-518. [PMID: 37256494 PMCID: PMC10652222 DOI: 10.1007/s11682-023-00781-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/29/2023] [Indexed: 06/01/2023]
Abstract
Brain gray matter (GM) reductions have been reported after breast cancer chemotherapy, typically in small and/or cross-sectional cohorts, most commonly using voxel-based morphometry (VBM). There has been little examination of approaches such as deformation-based morphometry (DBM), machine-learning-based brain aging metrics, or the relationship of clinical and demographic risk factors to GM reduction. This international data pooling study begins to address these questions. Participants included breast cancer patients treated with (CT+, n = 183) and without (CT-, n = 155) chemotherapy and noncancer controls (NC, n = 145), scanned pre- and post-chemotherapy or comparable intervals. VBM and DBM examined GM volume. Estimated brain aging was compared to chronological aging. Correlation analyses examined associations between VBM, DBM, and brain age, and between neuroimaging outcomes, baseline age, and time since chemotherapy completion. CT+ showed longitudinal GM volume reductions, primarily in frontal regions, with a broader spatial extent on DBM than VBM. CT- showed smaller clusters of GM reduction using both methods. Predicted brain aging was significantly greater in CT+ than NC, and older baseline age correlated with greater brain aging. Time since chemotherapy negatively correlated with brain aging and annual GM loss. This large-scale data pooling analysis confirmed findings of frontal lobe GM reduction after breast cancer chemotherapy. Milder changes were evident in patients not receiving chemotherapy. CT+ also demonstrated premature brain aging relative to NC, particularly at older age, but showed evidence for at least partial GM recovery over time. When validated in future studies, such knowledge could assist in weighing the risks and benefits of treatment strategies.
Collapse
Affiliation(s)
- Michiel B de Ruiter
- Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands
| | - Rachael L Deardorff
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Jeroen Blommaert
- Department of Oncology, KU Leuven, Leuven, Belgium and Research Foundation Flanders (FWO), Brussels, Belgium
| | - Bihong T Chen
- City of Hope National Medical Center, Duarte, CA, USA
| | | | - Sanne B Schagen
- Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands
- Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands
| | - Stefan Sunaert
- Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
- Department of Radiology, University Hospitals Leuven, Leuven, Belgium
| | - Lei Wang
- Wexner Medical Center, Ohio State University, Columbus, OH, USA
| | | | | | - Kim Dittus
- University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA
| | - Paul A Newhouse
- Center for Cognitive Medicine, Vanderbilt University Medical Center and Geriatric Research Educational and Clinical Center, Tennessee Valley VA Health System, Nashville, TN, USA
| | | | - Gwen Schroyen
- Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium
| | - Sabine Deprez
- Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
- Leuven Cancer Institute, KU Leuven, Leuven, Belgium
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
| |
Collapse
|
9
|
Ferguson RJ, Terhorst L, Gibbons B, Posluszny DM, Chang H, Bovbjerg DH, McDonald BC. Using Single-Case Experimental Design and Patient-Reported Outcome Measures to Evaluate the Treatment of Cancer-Related Cognitive Impairment in Clinical Practice. Cancers (Basel) 2023; 15:4643. [PMID: 37760621 PMCID: PMC10526413 DOI: 10.3390/cancers15184643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 09/13/2023] [Accepted: 09/18/2023] [Indexed: 09/29/2023] Open
Abstract
Cancer-related cognitive impairment (CRCI) affects a large proportion of cancer survivors and has significant negative effects on survivor function and quality of life (QOL). Treatments for CRCI are being developed and evaluated. Memory and attention adaptation training (MAAT) is a cognitive-behavioral therapy (CBT) demonstrated to improve CRCI symptoms and QOL in previous research. The aim of this article is to describe a single-case experimental design (SCED) approach to evaluate interventions for CRCI in clinical practice with patient-reported outcome measures (PROs). We illustrate the use of contemporary SCED methods as a means of evaluating MAAT, or any CRCI treatment, once clinically deployed. With the anticipated growth of cancer survivorship and concurrent growth in the number of survivors with CRCI, the treatment implementation and evaluation methods described here can be one way to assess and continually improve CRCI rehabilitative services.
Collapse
Affiliation(s)
- Robert J. Ferguson
- Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15232, USA; (D.M.P.); (H.C.)
| | - Lauren Terhorst
- Department of Occupational Therapy, School of Health Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA;
| | - Benjamin Gibbons
- Department of Family Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA;
| | - Donna M. Posluszny
- Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15232, USA; (D.M.P.); (H.C.)
| | - Hsuan Chang
- Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15232, USA; (D.M.P.); (H.C.)
| | - Dana H. Bovbjerg
- UPMC Hillman Cancer Center, Department of Psychiatry, Biobehavioral Cancer Control Program, University of Pittsburgh, Pittsburgh, PA 15232, USA;
| | - Brenna C. McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA;
| |
Collapse
|
10
|
Rentscher KE, Bethea TN, Zhai W, Small BJ, Zhou X, Ahles TA, Ahn J, Breen EC, Cohen HJ, Extermann M, Graham DM, Jim HS, McDonald BC, Nakamura ZM, Patel SK, Root JC, Saykin AJ, Van Dyk K, Mandelblatt JS, Carroll JE. Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study. Cancer 2023; 129:2741-2753. [PMID: 37259669 PMCID: PMC10659047 DOI: 10.1002/cncr.34818] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 03/22/2023] [Accepted: 03/29/2023] [Indexed: 06/02/2023]
Abstract
BACKGROUND Cancer and its treatments may accelerate aging in survivors; however, research has not examined epigenetic markers of aging in longer term breast cancer survivors. This study examined whether older breast cancer survivors showed greater epigenetic aging than noncancer controls and whether epigenetic aging related to functional outcomes. METHODS Nonmetastatic breast cancer survivors (n = 89) enrolled prior to systemic therapy and frequency-matched controls (n = 101) ages 62 to 84 years provided two blood samples to derive epigenetic aging measures (Horvath, Extrinsic Epigenetic Age [EEA], PhenoAge, GrimAge, Dunedin Pace of Aging) and completed cognitive (Functional Assessment of Cancer Therapy-Cognitive Function) and physical (Medical Outcomes Study Short Form-12) function assessments at approximately 24 to 36 and 60 months after enrollment. Mixed-effects models tested survivor-control differences in epigenetic aging, adjusting for age and comorbidities; models for functional outcomes also adjusted for racial group, site, and cognitive reserve. RESULTS Survivors were 1.04 to 2.22 years biologically older than controls on Horvath, EEA, GrimAge, and DunedinPACE measures (p = .001-.04) at approximately 24 to 36 months after enrollment. Survivors exposed to chemotherapy were 1.97 to 2.71 years older (p = .001-.04), and among this group, an older EEA related to worse self-reported cognition (p = .047) relative to controls. An older epigenetic age related to worse physical function in all women (p < .001-.01). Survivors and controls showed similar epigenetic aging over time, but Black survivors showed accelerated aging over time relative to non-Hispanic White survivors. CONCLUSION Older breast cancer survivors, particularly those exposed to chemotherapy, showed greater epigenetic aging than controls that may relate to worse outcomes. If replicated, measurement of biological aging could complement geriatric assessments to guide cancer care for older women.
Collapse
Affiliation(s)
- Kelly E. Rentscher
- Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee WI
- Norman Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Traci N. Bethea
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
| | - Wanting Zhai
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
| | - Brent J. Small
- School of Aging Studies, University of South Florida, Tampa, FL
| | - Xingtao Zhou
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
| | - Tim A. Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
| | - Elizabeth C. Breen
- Norman Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA
| | - Harvey Jay Cohen
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
| | | | - Deena M.A. Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
| | | | - Brenna C. McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN
| | - Zev M. Nakamura
- Department of Psychiatry, University of North Carolina–Chapel Hill, Chapel Hill, NC
| | | | - James C. Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Andrew J. Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN
| | - Kathleen Van Dyk
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | | | - Judith E. Carroll
- Norman Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| |
Collapse
|
11
|
Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim HSL, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Carroll JE. Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. Cancer 2023; 129:2409-2421. [PMID: 37096888 PMCID: PMC10750797 DOI: 10.1002/cncr.34784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Revised: 02/08/2023] [Accepted: 03/03/2023] [Indexed: 04/26/2023]
Abstract
BACKGROUND Immune activation/inflammation markers (immune markers) were tested to explain differences in neurocognition among older breast cancer survivors versus noncancer controls. METHODS Women >60 years old with primary breast cancer (stages 0-III) (n = 400) were assessed before systemic therapy with frequency-matched controls (n = 329) and followed annually to 60 months; blood was collected during annual assessments from 2016 to 2020. Neurocognition was measured by tests of attention, processing speed, and executive function (APE). Plasma levels of interleukin-6 (IL-6), IL-8, IL-10, tumor necrosis factor α (TNF-α), and interferon γ were determined using multiplex testing. Mixed linear models were used to compare results of immune marker levels by survivor/control group by time and by controlling for age, racial/ethnic group, cognitive reserve, and study site. Covariate-adjusted multilevel mediation analyses tested whether survivor/control group effects on cognition were explained by immune markers; secondary analyses examined the impact of additional covariates (e.g., comorbidity and obesity) on mediation effects. RESULTS Participants were aged 60-90 years (mean, 67.7 years). Most survivors had stage I (60.9%) estrogen receptor-positive tumors (87.6%). Survivors had significantly higher IL-6 levels than controls before systemic therapy and at 12, 24, and 60 months (p ≤ .001-.014) but there were no differences for other markers. Survivors had lower adjusted APE scores than controls (p < .05). Levels of IL-6, IL-10, and TNF-α were related to APE, with IL-6 explaining part of the relationship between survivor/control group and APE (p = .01). The magnitude of this mediation effect decreased but remained significant (p = .047) after the consideration of additional covariates. CONCLUSIONS Older breast cancer survivors had worse long-term neurocognitive performance than controls, and this relationship was explained in part by elevated IL-6.
Collapse
Affiliation(s)
- Jeanne S Mandelblatt
- Department of Oncology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA
- Georgetown Lombardi Institute for Cancer and Aging Research, Georgetown University's Lombardi Comprehensive Cancer Center, Washington, DC, USA
- Cancer Prevention and Control Program, Georgetown University's Lombardi Comprehensive Cancer Center, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, Tampa, Florida, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics, and Biomathematics, Department of Oncology and Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Zev M Nakamura
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Harvey J Cohen
- Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina, USA
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Department of Oncology and Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Traci N Bethea
- Department of Oncology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA
- Georgetown Lombardi Institute for Cancer and Aging Research, Georgetown University's Lombardi Comprehensive Cancer Center, Washington, DC, USA
- Cancer Prevention and Control Program, Georgetown University's Lombardi Comprehensive Cancer Center, Washington, DC, USA
| | - Martine Extermann
- Department of Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
| | - Deena Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, USA
| | - Claudine Isaacs
- Georgetown Lombardi Comprehensive Cancer Center, Department of Oncology, Department of Medicine, Georgetown University, Washington, DC, USA
| | - Paul B Jacobsen
- Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
| | - Heather S L Jim
- Cancer Prevention and Control Program, H. Lee Moffitt Comprehensive Cancer Center, Tampa, Florida, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Sunita K Patel
- City of Hope National Medical Center, Los Angeles, California, USA
| | - Kelly E Rentscher
- Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Danielle B Tometich
- Cancer Prevention and Control Program, H. Lee Moffitt Comprehensive Cancer Center, Tampa, Florida, USA
| | - Kathleen Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics, and Biomathematics, Department of Oncology and Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Elizabeth C Breen
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, USA
| | - Judith E Carroll
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, USA
| |
Collapse
|
12
|
Nudelman K, Nho K, Zhang M, McDonald BC, Zhai W, Small BJ, Wegel CE, Jacobsen PB, Jim HSL, Patel SK, Graham DMA, Ahles TA, Root JC, Foroud T, Breen EC, Carroll JE, Mandelblatt JS, Saykin AJ. Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls. Cancers (Basel) 2023; 15:2877. [PMID: 37296840 PMCID: PMC10252108 DOI: 10.3390/cancers15112877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 04/13/2023] [Accepted: 05/03/2023] [Indexed: 06/12/2023] Open
Abstract
Background: There have been no published genome-wide studies of the genetics of cancer- and treatment-related cognitive decline (CRCD); the purpose of this study is to identify genetic variants associated with CRCD in older female breast cancer survivors. Methods: Analyses included white non-Hispanic women with non-metastatic breast cancer aged 60+ (N = 325) and age-, racial/ethnic group-, and education-matched controls (N = 340) with pre-systemic treatment and one-year follow-up cognitive assessment. CRCD was evaluated using longitudinal domain scores on cognitive tests of attention, processing speed, and executive function (APE), and learning and memory (LM). Linear regression models of one-year cognition included an interaction term for SNP or gene SNP enrichment*cancer case/control status, controlling for demographic variables and baseline cognition. Results: Cancer patients carrying minor alleles for two SNPs, rs76859653 (chromosome 1) in the hemicentin 1 (HMCN1) gene (p = 1.624 × 10-8), and rs78786199 (chromosome 2, p = 1.925 × 10-8) in an intergenic region had lower one-year APE scores than non-carriers and controls. Gene-level analyses showed the POC5 centriolar protein gene was enriched for SNPs associated with differences in longitudinal LM performance between patients and controls. Conclusions: The SNPs associated with cognition in survivors, but not controls, were members of the cyclic nucleotide phosphodiesterase family, that play important roles in cell signaling, cancer risk, and neurodegeneration. These findings provide preliminary evidence that novel genetic loci may contribute to susceptibility to CRCD.
Collapse
Affiliation(s)
- Kelly Nudelman
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana University Genetics Biobank, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Kwangsik Nho
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Michael Zhang
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana University Genetics Biobank, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Brenna C. McDonald
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Wanting Zhai
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
| | - Brent J. Small
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
- School of Aging Studies, University of South Florida, Tampa, FL 33620, USA
| | - Claire E. Wegel
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana University Genetics Biobank, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Paul B. Jacobsen
- Division of Cancer Control and Population Studies, National Cancer Institute, Bethesda, MD 20892, USA
| | - Heather S. L. Jim
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
| | - Sunita K. Patel
- Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
| | - Deena M. A. Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA
| | - Tim A. Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
| | - James C. Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
| | - Tatiana Foroud
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana University Genetics Biobank, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Elizabeth C. Breen
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA 90095, USA
- Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA
| | - Judith E. Carroll
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA 90095, USA
- Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA
| | - Jeanne S. Mandelblatt
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
| | - Andrew J. Saykin
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| |
Collapse
|
13
|
Hirschfeld LR, Deardorff R, Chumin EJ, Wu YC, McDonald BC, Cao S, Risacher SL, Yi D, Byun MS, Lee JY, Kim YK, Kang KM, Sohn CH, Nho K, Saykin AJ, Lee DY. White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum. medRxiv 2023:2023.04.05.23288147. [PMID: 37066317 PMCID: PMC10104207 DOI: 10.1101/2023.04.05.23288147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/18/2023]
Abstract
BACKGROUND White matter (WM) microstructural changes in the hippocampal cingulum bundle (CBH) in Alzheimer's disease (AD) have been described in cohorts of largely European ancestry but are lacking in other populations. METHODS We assessed the relationship between CBH WM integrity and cognition or amyloid burden in 505 Korean older adults aged ≥55 years, including 276 cognitively normal older adults (CN), 142 mild cognitive impairment (MCI), and 87 AD, recruited as part of the Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's disease (KBASE) at Seoul National University. RESULTS Compared to CN, AD and MCI subjects showed decreased WM integrity in the bilateral CBH. Cognition, mood, and higher amyloid burden were also associated with poorer WM integrity in the CBH. CONCLUSION These findings are consistent with patterns of WM microstructural damage previously reported in non-Hispanic White (NHW) MCI/AD cohorts, reinforcing existing evidence from predominantly NHW cohort studies.
Collapse
Affiliation(s)
- Lauren Rose Hirschfeld
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Rachael Deardorff
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Evgeny J Chumin
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN USA, 47405
| | - Yu-Chien Wu
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Brenna C McDonald
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Sha Cao
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Biostatistics and Health Data Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Shannon L Risacher
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Dahyun Yi
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, Korea, 03080
| | - Min Soo Byun
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea, 03080
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea, 03080
| | - Jun-Young Lee
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea, 03080
- Department of Neuropsychiatry, SMG-SNU Boramae Medical Center, Seoul, Korea, 07061
| | - Yu Kyeong Kim
- Department of Nuclear Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, 07061
| | - Koung Mi Kang
- Department of Radiology, Seoul National University Hospital, Seoul, Korea, 03080
| | - Chul-Ho Sohn
- Department of Radiology, Seoul National University Hospital, Seoul, Korea, 03080
| | - Kwangsik Nho
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Indiana University School of Informatics and Computing, Indianapolis, IN USA, 46202
| | - Andrew J Saykin
- Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN USA, 46202
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN USA, 46202
| | - Dong Young Lee
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, Korea, 03080
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea, 03080
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea, 03080
| |
Collapse
|
14
|
Tometich DB, Mosher CE, Cyders M, McDonald BC, Saykin AJ, Small BJ, Zhai W, Zhou X, Jim HSL, Jacobsen P, Ahles TA, Root JC, Graham D, Patel SK, Mandelblatt J. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Ann Behav Med 2023; 57:237-248. [PMID: 36356044 PMCID: PMC10074030 DOI: 10.1093/abm/kaac048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Older cancer survivors are at risk for cognitive decline. Physical activity can improve cognition, and better cognitive function may facilitate greater physical activity. PURPOSE We examined the potential bidirectional relationship between cognitive function and physical activity in older breast cancer survivors and controls. METHODS The sample included women with newly diagnosed, nonmetastatic breast cancer (n = 395) and women without cancer (n = 374) ages 60-98. Participants were recruited as part of a larger multisite study, assessed prior to systemic therapy, and followed yearly for 36 months. Attention, processing speed, and executive function was measured using six neuropsychological tests, self-reported cognitive function using the Perceived Cognitive Impairments subscale of the Functional Assessment of Cancer Therapy-Cognitive Function , and physical activity using the International Physical Activity Questionnaire-Short Form. Separate random intercepts cross-lagged panel models were used to examine the between- and within-person effects for survivors and controls, controlling for age, education, and study site. RESULTS Survivors reported significantly less physical activity than controls at baseline (1,284.92 vs. 2,085.98 MET min/week, p < .05). When survivors reported higher activity, they simultaneously had better objective cognition at 12 months (β = 0.24, p = .04) and reported better perceived cognition at 12 and 24 months (β = 0.25, p = .03), but this relationship was not seen in controls. Cognition did not predict subsequent physical activity or vice versa in either group. CONCLUSIONS Cognition and physical activity are cross-sectionally associated in survivors, but the expected prospective relationships were not found.
Collapse
Affiliation(s)
- Danielle B Tometich
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA
| | - Catherine E Mosher
- Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA
| | - Melissa Cyders
- Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA
| | - Brenna C McDonald
- Department of Radiology & Imaging Sciences, School of Medicine, Indiana University, Indianapolis, IN, USA
| | - Andrew J Saykin
- Department of Radiology & Imaging Sciences, School of Medicine, Indiana University, Indianapolis, IN, USA
| | - Brent J Small
- College of Behavioral and Community Sciences, School of Aging Studies, University of South Florida, Tampa, FL, USA
| | - Wanting Zhai
- Department of Oncology, School of Medicine, Georgetown University, Washington, DC, USA
| | - Xingtao Zhou
- Department of Oncology, School of Medicine, Georgetown University, Washington, DC, USA
| | - Heather S L Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA
| | - Paul Jacobsen
- Division of Cancer Control and Population Sciences, National Institutes of Health, Bethesda, MD, USA
| | - Tim A Ahles
- Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York City, NY, USA
| | - James C Root
- Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York City, NY, USA
| | - Deena Graham
- Department of Oncology, John Theurer Cancer Center, Hackensack, NJ, USA
| | - Sunita K Patel
- Department of Population Sciences, City of Hope, Duarte, CA, USA
| | - Jeanne Mandelblatt
- Department of Oncology, School of Medicine, Georgetown University, Washington, DC, USA
| |
Collapse
|
15
|
Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Jim HS, McDonald BC, Patel SK, Rentscher K, Root J, Saykin AJ, Dyk KV, Zhai W, Breen EC, Carroll JE. Abstract A012: Differences in attention, processing speed, and executive function in older breast cancer survivors compared to controls is partially explained by plasma IL-6: The Thinking and Living with Cancer (TLC) Study. Cancer Res 2023. [DOI: 10.1158/1538-7445.agca22-a012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Abstract
Purpose: Cancer-related cognitive problems may result from peripheral inflammation effects on the brain. We tested whether differences in cognitive performance between breast cancer survivors and non-cancer controls was explained by elevated inflammatory cytokines. Methods: We enrolled women >60 years, newly diagnosed with primary breast cancer (stage 0-III) (n=400) and frequency-matched non-cancer controls (n=329) from six national centers from 2010- 2020, with blood collection beginning in 2016. Baseline assessments occurred pre-systemic therapy (or enrollment for controls) with annual follow-up to 60-months. The primary outcome was the score on neurocognitive tests of the attention, processing speed and executive function (APE) domain. Plasma levels of IL-6, IL-10, and TNF-alpha were determined using multiplex testing and mixed linear models compared results for each marker across all timepoints by survivor/control group, adjusting for age, race, WRAT scores, recruitment site, comorbidities, and BMI. Multi-level mediation analyses tested the simultaneous direct effects of survivor/control group on cognition and indirect effects of group on each immune marker and the effect of the marker on cognition, controlling for covariates. Results: Participants had an average age of 67.7 years (range: 60-90). Most survivors had stage I (60.9%) estrogen-receptor positive (87.6%) tumors. Survivors had significantly higher adjusted IL-6 levels than controls at baseline, 12-, 24- and 60-months (p=< 0.001 to 0.014), but there were no differences for other markers. Survivors had lower adjusted APE scores than controls, and this effect was due to the indirect effects of being a survivor vs. control on IL-6 (p=0.047). Conclusion: Cancer and its treatments were related to poorer attention, processing speed, and executive function compared to non-cancer frequency matched controls, and this difference was partially explained by elevated IL-6.
Citation Format: Jeanne S. Mandelblatt, Brent J. Small, Xingtao Zhou, Zev M. Nakamura, Harvey J. Cohen, Tim A. Ahles, Jaeil Ahn, Traci N. Bethea, Martine Extermann, Heather S.L. Jim, Brenna C. McDonald, Sunita K. Patel, Kelly Rentscher, James Root, Andrew J. Saykin, Kathleen Van Dyk, Wanting Zhai, Elizabeth C. Breen, Judith E. Carroll. Differences in attention, processing speed, and executive function in older breast cancer survivors compared to controls is partially explained by plasma IL-6: The Thinking and Living with Cancer (TLC) Study [abstract]. In: Proceedings of the AACR Special Conference: Aging and Cancer; 2022 Nov 17-20; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2022;83(2 Suppl_1):Abstract nr A012.
Collapse
Affiliation(s)
| | | | | | | | | | - Tim A. Ahles
- 6Memorial Sloan Kettering Cancer Center, New York, NY,
| | - Jaeil Ahn
- 3Georgetown University, Washington, DC,
| | | | | | | | | | | | | | - James Root
- 6Memorial Sloan Kettering Cancer Center, New York, NY,
| | | | | | | | | | | |
Collapse
|
16
|
Rentscher KE, Zhai W, Small BJ, Ahn J, Ahles TA, Bethea TN, Breen EC, Cohen HJ, Extermann M, Graham DM, Jacobsen PB, Jim HS, McDonald BC, Nakamura ZM, Patel SK, Root JC, Saykin AJ, Tometich DB, Dyk KMV, Zhou X, Mandelblatt JS, Carroll JE. Abstract B018: Long-term epigenetic aging in older breast cancer survivors and non-cancer controls: Preliminary findings from the Thinking and Living with Cancer (TLC) Stud. Cancer Res 2023. [DOI: 10.1158/1538-7445.agca22-b018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Abstract
Cancer and its treatments are thought to increase risk for accelerated aging in survivors, and biological aging may be a key mechanism; however, no research to date has examined epigenetic markers of aging in long-term breast cancer survivors. We used data from the Thinking and Living with Cancer (TLC) study to examine whether older breast cancer survivors have accelerated epigenetic aging compared to non-cancer controls several years after treatment completion and whether epigenetic aging related to cognitive and physical function. Non-metastatic breast cancer survivors ages 62–84 years (n=89) and frequency-matched controls (n=101) provided two blood samples between 24- and 60-months post-diagnosis. DNA methylation profiling (Illumina Infinium EPIC array) derived epigenetic aging measures: Horvath, Hannum, PhenoAge, GrimAge, and Dunedin Pace of Aging Methylation. Participants completed neuropsychological testing and questionnaires to assess cognitive and physical function at each visit. Mixed-effects models adjusted for chronological age and comorbidities and applied false discovery rate correction for multiple testing. Survivors were 1.04–2.22 years older biologically than controls at the first blood sample based on Horvath, Hannum, and GrimAge measures (corrected ps=.025, .025, and .058, respectively), with marginal differences for Dunedin Pace of Aging (corrected p=.096); however, survivors and controls showed similar changes in epigenetic aging over time. Exposure to prior chemotherapy (with or without hormonal therapy; n=29) was associated with an epigenetic age 1.97–2.71 years older than controls (corrected ps=.005 to .065). Among survivors who received chemotherapy, an older Hannum epigenetic age was associated with poorer self-reported cognition relative to controls (coeff=-0.64, uncorrected p=.047; n.s. after correction). Older breast cancer survivors, particularly those receiving chemotherapy, showed an accelerated epigenetic aging profile compared to their peers without cancer at 24 months or more post-diagnosis, following the completion of active therapy. This study also provides preliminary evidence that survivors who received chemotherapy may be at increased risk for poorer age-related survivorship outcomes.
Citation Format: Kelly E. Rentscher, Wanting Zhai, Brent J. Small, Jaeil Ahn, Tim A. Ahles, Traci N. Bethea, Elizabeth C. Breen, Harvey J. Cohen, Martine Extermann, Deena M.A. Graham, Paul B. Jacobsen, Heather S.L. Jim, Brenna C. McDonald, Zev M. Nakamura, Sunita K. Patel, James C. Root, Andrew J. Saykin, Danielle B. Tometich, Kathleen M. Van Dyk, Xingtao Zhou, Jeanne S. Mandelblatt, Judith E. Carroll. Long-term epigenetic aging in older breast cancer survivors and non-cancer controls: Preliminary findings from the Thinking and Living with Cancer (TLC) Stud [abstract]. In: Proceedings of the AACR Special Conference: Aging and Cancer; 2022 Nov 17-20; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2022;83(2 Suppl_1):Abstract nr B018.
Collapse
Affiliation(s)
| | | | | | - Jaeil Ahn
- 2Georgetown University, Washington, DC,
| | - Tim A. Ahles
- 4Memorial Sloan Kettering Cancer Center, New York, NY,
| | | | | | | | | | | | | | | | | | - Zev M. Nakamura
- 10University of North Carolina-Chapel Hill, Chapel Hill, NC,
| | | | - James C. Root
- 4Memorial Sloan Kettering Cancer Center, New York, NY,
| | | | | | | | | | | | | |
Collapse
|
17
|
Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jim HS, Jacobsen PB, McDonald BC, Patel SK, Rentscher K, Root J, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Mandelblatt JS. Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. J Clin Oncol 2023; 41:295-306. [PMID: 36179271 PMCID: PMC9839283 DOI: 10.1200/jco.22.00406] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Revised: 05/24/2022] [Accepted: 07/26/2022] [Indexed: 01/25/2023] Open
Abstract
PURPOSE To examine longitudinal relationships between levels of C-reactive protein (CRP) and cognition in older breast cancer survivors and noncancer controls. METHODS English-speaking women age ≥ 60 years, newly diagnosed with primary breast cancer (stage 0-III), and frequency-matched controls were enrolled from September 2010 to March 2020; women with dementia, neurologic disorders, and other cancers were excluded. Assessments occurred presystemic therapy/enrollment and at annual visits up to 60 months. Cognition was measured using the Functional Assessment of Cancer Therapy-Cognitive Function and neuropsychological testing. Mixed linear effect models tested for survivor-control differences in natural log (ln)-transformed CRP at each visit. Random effect-lagged fluctuation models tested directional effects of ln-CRP on subsequent cognition. All models controlled for age, race, study site, cognitive reserve, obesity, and comorbidities; secondary analyses evaluated if depression or anxiety affected results. RESULTS There were 400 survivors and 329 controls with CRP specimens and follow-up data (average age of 67.7 years; range, 60-90 years). The majority of survivors had stage I (60.9%), estrogen receptor-positive (87.6%) tumors. Survivors had significantly higher adjusted mean ln-CRP than controls at baseline and 12-, 24-, and 60-month visits (all P < .05). Higher adjusted ln-CRP predicted lower participant-reported cognition on subsequent visits among survivors, but not controls (P interaction = .008); effects were unchanged by depression or anxiety. Overall, survivors had adjusted Functional Assessment of Cancer Therapy-Cognitive Function scores that were 9.5 and 14.2 points lower than controls at CRP levels of 3.0 and 10.0 mg/L. Survivors had poorer neuropsychological test performance (v controls), with significant interactions with CRP only for the Trails B test. CONCLUSION Longitudinal relationships between CRP and cognition in older breast cancer survivors suggest that chronic inflammation may play a role in development of cognitive problems. CRP testing could be clinically useful in survivorship care.
Collapse
Affiliation(s)
- Judith E. Carroll
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Zev M. Nakamura
- Department of Psychiatry, University of North Carolina–Chapel Hill, Chapel Hill, NC
| | - Brent J. Small
- School of Aging Studies, University of South Florida, Tampa, FL
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| | - Harvey J. Cohen
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
| | - Tim A. Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| | - Traci N. Bethea
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| | - Martine Extermann
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL
| | - Deena Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
| | - Claudine Isaacs
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| | | | - Paul B. Jacobsen
- Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD
| | - Brenna C. McDonald
- Department of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN
| | | | - Kelly Rentscher
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - James Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Andrew J. Saykin
- Department of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN
| | | | - Kathleen Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| | - Elizabeth C. Breen
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Jeanne S. Mandelblatt
- Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC
| |
Collapse
|
18
|
Van Dyk K, Ahn J, Zhou X, Zhai W, Ahles TA, Bethea TN, Carroll JE, Cohen HJ, Dilawari AA, Graham D, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Saykin AJ, Small BJ, Mandelblatt JS, Root JC. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study. J Geriatr Oncol 2022; 13:1132-1140. [PMID: 36030173 PMCID: PMC10016202 DOI: 10.1016/j.jgo.2022.08.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Revised: 07/16/2022] [Accepted: 08/10/2022] [Indexed: 01/31/2023]
Abstract
INTRODUCTION Many cancer survivors report cognitive problems following diagnosis and treatment. However, the clinical significance of patient-reported cognitive symptoms early in survivorship can be unclear. We used a machine learning approach to determine the association of persistent self-reported cognitive symptoms two years after diagnosis and neurocognitive test performance in a prospective cohort of older breast cancer survivors. MATERIALS AND METHODS We enrolled breast cancer survivors with non-metastatic disease (n = 435) and age- and education-matched non-cancer controls (n = 441) between August 2010 and December 2017 and followed until January 2020; we excluded women with neurological disease and all women passed a cognitive screen at enrollment. Women completed the FACT-Cog Perceived Cognitive Impairment (PCI) scale and neurocognitive tests of attention, processing speed, executive function, learning, memory and visuospatial ability, and timed activities of daily living assessments at enrollment (pre-systemic treatment) and annually to 24 months, for a total of 59 individual neurocognitive measures. We defined persistent self-reported cognitive decline as clinically meaningful decline (3.7+ points) on the PCI scale from enrollment to twelve months with persistence to 24 months. Analysis used four machine learning models based on data for change scores (baseline to twelve months) on the 59 neurocognitive measures and measures of depression, anxiety, and fatigue to determine a set of variables that distinguished the 24-month persistent cognitive decline group from non-cancer controls or from survivors without decline. RESULTS The sample of survivors and controls ranged in age from were ages 60-89. Thirty-three percent of survivors had self-reported cognitive decline at twelve months and two-thirds continued to have persistent decline to 24 months (n = 60). Least Absolute Shrinkage and Selection Operator (LASSO) models distinguished survivors with persistent self-reported declines from controls (AUC = 0.736) and survivors without decline (n = 147; AUC = 0.744). The variables that separated groups were predominantly neurocognitive test performance change scores, including declines in list learning, verbal fluency, and attention measures. DISCUSSION Machine learning may be useful to further our understanding of cancer-related cognitive decline. Our results suggest that persistent self-reported cognitive problems among older women with breast cancer are associated with a constellation of mild neurocognitive changes warranting clinical attention.
Collapse
Affiliation(s)
- Kathleen Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, CA, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, United States of America.
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, United States of America
| | - Xingtao Zhou
- Georgetown Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, United States of America
| | - Wanting Zhai
- Georgetown Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, United States of America
| | - Tim A Ahles
- Memorial Sloan Kettering Cancer Center, New York, NY, United States of America
| | - Traci N Bethea
- Georgetown Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, United States of America
| | - Judith E Carroll
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, CA, United States of America; Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA, United States of America
| | - Harvey Jay Cohen
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, United States of America
| | - Asma A Dilawari
- Georgetown Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, United States of America
| | - Deena Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States of America
| | - Paul B Jacobsen
- Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, United States of America
| | - Heather Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States of America
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States of America
| | - Zev M Nakamura
- Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States of America
| | - Sunita K Patel
- City of Hope National Medical Center, Los Angeles, CA, United States of America
| | - Kelly E Rentscher
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, CA, United States of America; Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA, United States of America
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States of America
| | - Brent J Small
- University of South Florida, Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center, Research Institute at the University of South Florida, Tampa, FL, United States of America
| | - Jeanne S Mandelblatt
- Georgetown Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, United States of America
| | - James C Root
- Memorial Sloan Kettering Cancer Center, New York, NY, United States of America
| |
Collapse
|
19
|
Conley AC, Albert KM, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA. Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance. Hum Psychopharmacol 2022; 37:e2838. [PMID: 35212023 PMCID: PMC9399322 DOI: 10.1002/hup.2838] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Revised: 02/02/2022] [Accepted: 02/07/2022] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Older women are at increased risk of developing Alzheimer's disease compared to men. One proposed reason is that following menopause there is a decline in estrogens. Estrogens are important for cholinergic functioning and attenuate the impact of cholinergic antagonists on cognitive performance in postmenopausal women. Self-reported or subjective cognitive complaints in middle or older age may represent a harbinger of cognitive decline and those who endorse cognitive complaints appear more likely to develop future cognitive impairment. However, the response of individuals with cognitive complaints after menopause to estrogen and the relationship to cholinergic functioning has not been investigated. This study investigated the effect of estrogen treatment using 17β-estradiol on cognitive performance following anticholinergic blockade in postmenopausal women and the relationship of this interaction with the level of self-reported (subjective) postmenopausal cognitive complaints. METHODS Forty postmenopausal women (aged 50-60 years) completed a 3-month treatment regimen of either 1 mg oral estradiol or placebo. Participants then completed four challenge days in which they completed cognitive and behavioral tasks after one of four cholinergic antagonist drug conditions (oral mecamylamine (MECA), intravenous scopolamine, combined MECA and scopolamine, or PLC). RESULTS Compared to PLC, the estradiol treated group performed worse on attention tasks under cholinergic challenge including the choice reaction time task and the critical flicker fusion task. In addition, participants who endorsed greater cognitive complaints showed reduced performance on the N-back working memory task, regardless of whether they received estradiol treatment. CONCLUSIONS The findings of this study indicate that estradiol treatment was unable to mitigate anticholinergic blockade in postmenopausal women with subjective cognitive complaints, and worsened performance on attention tasks. Moreover, the present study suggests that greater levels of cognitive complaints following menopause may be associated with an underlying decline in cholinergic function that may manifest as an inability to compensate during working memory tasks.
Collapse
Affiliation(s)
- Alexander C. Conley
- Department of Psychiatry, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Kimberly M. Albert
- Department of Psychiatry, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Brenna C. McDonald
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, USA
| | - Andrew J. Saykin
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, USA
| | - Julie A. Dumas
- Department of Psychiatry, Clinical Neuroscience Research Unit, University of Vermont College of Medicine, Burlington, Vermont, USA
| | - Paul A. Newhouse
- Department of Psychiatry, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA,Geriatric Research, Education, and Clinical Center, Veterans Affairs Tennessee Valley Health System, Nashville, Tennessee, USA
| |
Collapse
|
20
|
Bethea TN, Zhai W, Zhou X, Ahles TA, Ahn J, Cohen HJ, Dilawari AA, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Root J, Saykin AJ, Small BJ, Van Dyk KM, Mandelblatt JS, Carroll JE. Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study. Cancer Med 2022; 11:3352-3363. [PMID: 35315588 PMCID: PMC9110906 DOI: 10.1002/cam4.4682] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2021] [Revised: 02/25/2022] [Accepted: 02/28/2022] [Indexed: 12/16/2022] Open
Abstract
PURPOSE Several studies have reported sleep disturbances during the COVID-19 virus pandemic. Little data exist about the impact of the pandemic on sleep and mental health among older women with breast cancer. We sought to examine whether women with and without breast cancer who experienced new sleep problems during the pandemic had worsening depression and anxiety. METHODS Breast cancer survivors aged ≥60 years with a history of nonmetastatic breast cancer (n = 242) and frequency-matched noncancer controls (n = 158) active in a longitudinal cohort study completed a COVID-19 virus pandemic survey from May to September 2020 (response rate 83%). Incident sleep disturbance was measured using the restless sleep item from the Center for Epidemiological Studies-Depression Scale (CES-D). CES-D score (minus the sleep item) captured depressive symptoms; the State-Anxiety subscale of the State Trait Anxiety Inventory measured anxiety symptoms. Multivariable linear regression models examined how the development of sleep disturbance affected changes in depressive or anxiety symptoms from the most recent prepandemic survey to the pandemic survey, controlling for covariates. RESULTS The prevalence of sleep disturbance during the pandemic was 22.3%, with incident sleep disturbance in 10% and 13.5% of survivors and controls, respectively. Depressive and anxiety symptoms significantly increased during the pandemic among women with incident sleep disturbance (vs. no disturbance) (β = 8.16, p < 0.01 and β = 6.14, p < 0.01, respectively), but there were no survivor-control differences in the effect. CONCLUSION Development of sleep disturbances during the COVID-19 virus pandemic may negatively affect older women's mental health, but breast cancer survivors diagnosed with the nonmetastatic disease had similar experiences as women without cancer.
Collapse
Affiliation(s)
- Traci N. Bethea
- Office of Minority Health and Health Disparities ResearchGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
- Cancer Prevention and Control ProgramGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
| | - Wanting Zhai
- Cancer Prevention and Control ProgramGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
| | - Xingtao Zhou
- Cancer Prevention and Control ProgramGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
| | - Tim A. Ahles
- Department of Psychiatry and Behavioral SciencesMemorial Sloan Kettering Cancer CenterNew YorkNew York CityUSA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and BiomathematicsGeorgetown UniversityWashingtonDistrict of ColumbiaUSA
| | - Harvey J. Cohen
- Center for the Study of Aging and Human DevelopmentDuke University Medical CenterDurhamNorth CarolinaUSA
| | - Asma A. Dilawari
- Cancer Prevention and Control ProgramGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
- Medstar Washington Hospital CenterWashingtonDistrict of ColumbiaUSA
| | - Deena M. A. Graham
- John Theurer Cancer CenterHackensack University Medical CenterHackensackNew JerseyUSA
| | | | - Brenna C. McDonald
- Department of Radiology and Imaging SciencesIndiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolisIndianaUSA
| | - Zev M. Nakamura
- Department of PsychiatryUniversity of North Carolina‐Chapel HillChapel HillNorth CarolinaUSA
| | - Sunita K. Patel
- City of Hope National Medical CenterLos AngelesCaliforniaUSA
| | - Kelly E. Rentscher
- Cousins Center for PsychoneuroimmunologyUniversity of California, Los AngelesLos AngelesCaliforniaUSA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral SciencesUniversity of California, Los AngelesLos AngelesCaliforniaUSA
| | - James Root
- Department of Psychiatry and Behavioral SciencesMemorial Sloan Kettering Cancer CenterNew YorkNew York CityUSA
| | - Andrew J. Saykin
- Department of Radiology and Imaging SciencesIndiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolisIndianaUSA
| | - Brent J. Small
- College of Behavioral and Community Sciences, School of Aging StudiesUniversity of South FloridaTampaFloridaUSA
| | - Kathleen M. Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral SciencesUniversity of California, Los AngelesLos AngelesCaliforniaUSA
| | - Jeanne S. Mandelblatt
- Cancer Prevention and Control ProgramGeorgetown Lombardi Comprehensive Cancer CenterWashingtonDistrict of ColumbiaUSA
| | - Judith E. Carroll
- Cousins Center for PsychoneuroimmunologyUniversity of California, Los AngelesLos AngelesCaliforniaUSA
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral SciencesUniversity of California, Los AngelesLos AngelesCaliforniaUSA
| |
Collapse
|
21
|
Von Ah D, McDonald BC, Crouch AD, Ofner S, Perkins S, Storey S, Considine R, Unverzagt F. Randomized double-masked controlled trial of cognitive training in breast cancer survivors: a preliminary study. Support Care Cancer 2022; 30:7457-7467. [PMID: 35648204 PMCID: PMC9156616 DOI: 10.1007/s00520-022-07182-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Accepted: 05/26/2022] [Indexed: 11/26/2022]
Abstract
PURPOSE To evaluate the acceptability, satisfaction, and preliminary efficacy of cognitive training for improving cognitive function and health outcomes in breast cancer survivors (BCS). PATIENTS AND METHODS BCS enrolled in this 2-group randomized, double-masked controlled trial of cognitive training. Primary outcomes included the acceptability and satisfaction of the interventions. Secondary outcomes included examining the effect size and reliable improvement of perceived cognitive function and health outcomes, including work ability, health perception (status and change), and quality of life. Exploratory outcomes were performance on neuropsychological tests and plasma levels of brain-derived neurotropic factor (BDNF). Data were collected at baseline and immediately post-intervention. Using ANCOVA models, the intervention was compared to attention control while adjusting for covariates and baseline values. The effect sizes for differences in means and the reliable improvement percentage were reported. RESULTS Thirty-six BCS completed the study and were on average 57.6 (SD = 8.0) years old, 59.4% Caucasian, and had some college education (74.5%). Both programs were reported to be satisfactory and acceptable. Non-significant small effect sizes were noted for the intervention on cognitive abilities (d = 0.26) and cognitive concerns (d = - 0.32), with reliable improvement noted in 32% and 28% of BCS, respectively. Small to medium effect sizes were noted in improvement in work ability (d = 0.37) and health perception status (d = 0.30) and change (d = 0.60, p < 0.05). CONCLUSIONS Cognitive training was acceptable to BCS and resulted in improvement in perceived cognitive function and perceptions of "real-world" health benefits. A larger randomized controlled trial is warranted to determine its effectiveness for objective cognitive performance.
Collapse
Affiliation(s)
- Diane Von Ah
- Ohio State University College of Nursing, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210 USA
| | | | - Adele D. Crouch
- NewCourtland Center for Transitions and Health, University of Pennsylvania School of Nursing, Philadelphia, PA USA
| | - Susan Ofner
- Indiana University School of Medicine, Indianapolis, IN USA
| | - Susan Perkins
- Indiana University School of Medicine, Indianapolis, IN USA
| | - Susan Storey
- School of Nursing, Indiana University, Indianapolis, IN 46202 USA
| | | | - Fred Unverzagt
- Department of Psychiatry, School of Medicine, Indiana University, Indianapolis, IN USA
| |
Collapse
|
22
|
McDonald BC, Van Dyk K, Deardorff RL, Bailey JN, Zhai W, Carroll JE, Root JC, Ahles TA, Mandelblatt JS, Saykin AJ. Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy. Breast Cancer Res Treat 2022; 194:113-126. [PMID: 35476252 PMCID: PMC9255382 DOI: 10.1007/s10549-022-06597-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Accepted: 04/05/2022] [Indexed: 11/29/2022]
Abstract
PURPOSE Cancer patients are concerned about treatment-related cognitive problems. We examined effects of antiestrogen hormonal therapy on brain imaging metrics in older women with breast cancer. METHODS Women aged 60 + treated with hormonal therapy only and matched non-cancer controls (n = 29/group) completed MRI and objective and self-reported cognitive assessment at pre-treatment/enrollment and 12 months later. Gray matter was examined using voxel-based morphometry (VBM), FreeSurfer, and brain age calculations. Functional MRI (fMRI) assessed working memory-related activation. Analyses examined cross-sectional and longitudinal differences and tested associations between brain metrics, cognition, and days on hormonal therapy. RESULTS The cancer group showed regional reductions over 12 months in frontal, temporal, and parietal gray matter on VBM, reduced FreeSurfer cortical thickness in prefrontal, parietal, and insular regions, and increased working memory-related fMRI activation in frontal, cingulate, and visual association cortex. Controls showed only reductions in fusiform gyrus on VBM and FreeSurfer temporal and parietal cortex thickness. Women with breast cancer showed higher estimated brain age and lower regional gray matter volume than controls at both time points. The cancer group showed a trend toward lower performance in attention, processing speed, and executive function at follow-up. There were no significant associations between brain imaging metrics and cognition or days on hormonal therapy. CONCLUSION Older women with breast cancer showed brain changes in the first year of hormonal therapy. Increased brain activation during working memory processing may be a sign of functional compensation for treatment-related structural changes. This hypothesis should be tested in larger samples over longer time periods. CLINICALTRIALS GOV IDENTIFIER NCT03451383.
Collapse
Affiliation(s)
- Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
| | - Kathleen Van Dyk
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine and UCLA Jonnson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA
| | - Rachael L Deardorff
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA
| | - Jessica N Bailey
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA
| | - Wanting Zhai
- Georgetown University and Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
| | - Judith E Carroll
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine and UCLA Jonnson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA
| | - James C Root
- Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Tim A Ahles
- Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jeanne S Mandelblatt
- Georgetown University and Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA
| |
Collapse
|
23
|
Root JC, Zhou X, Ahn J, Small BJ, Zhai W, Bethea T, Carroll JE, Cohen HJ, Dilawari A, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher K, Saykin AJ, Van Dyk K, Mandelblatt JS, Ahles TA. Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study. Breast Cancer Res Treat 2022; 194:413-422. [PMID: 35587324 PMCID: PMC9392482 DOI: 10.1007/s10549-022-06623-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Accepted: 04/30/2022] [Indexed: 01/13/2023]
Abstract
PURPOSE Tumor features associated with aggressive cancers may affect cognition prior to systemic therapy. We evaluated associations of cognition prior to adjuvant therapy and tumor aggressivity in older breast cancer patients. METHODS Women diagnosed with non-metastatic breast cancer (n = 705) ages 60-98 were enrolled from August 2010-March 2020. Cognition was measured post-surgery, pre-systemic therapy using self-reported (FACT-Cog Perceived Cognitive Impairment [PCI]) and objective tests of attention, processing speed, and executive function (APE domain) and learning and memory [LM domain]. Linear regression tested associations of pre-treatment tumor features and cognition, adjusting for age, race, and study site. HER2 positivity and higher stage (II/III vs. 0/I) were a priori predictors of cognition; in secondary analyses we explored associations of other tumor features and cognitive impairment (i.e., PCI score < 54 or having 2 tests < 1.5 SD or 1 test < 2 SD from the mean APE or LM domain score). RESULTS HER2 positivity and the hormone receptor negative/HER2 + molecular subtype were associated with lower adjusted mean self-reported cognition scores and higher impairment rates (p values < .05). Higher stage of disease was associated with lower objective performance in APE. Other tumor features were associated with cognition in unadjusted and adjusted models, including larger tumor size and lower PCI scores (p = 0.02). Tumor features were not related to LM. CONCLUSIONS Pre-adjuvant therapy cognition was associated with HER2 positivity and higher stage of disease and other features of aggressive tumors. Additional research is needed to confirm these results and assess potential mechanisms and clinical management strategies.
Collapse
Affiliation(s)
- James C Root
- Neurocognitive Research Lab, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Avenue, 7th Floor, New York, NY, USA.
- Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA.
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, and Senior Member, Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Traci Bethea
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Judith E Carroll
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human BehaviorJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA
| | - Harvey Jay Cohen
- Center for the Study of Aging and Human Development and Comprehensive Cancer Center, Duke University School of Medicine, Durham, NC, USA
| | - Asma Dilawari
- MedStar Washington Hospital Center, MedStar Georgetown Lombardi Comprehensive Cancer Center, Washington, USA
| | - Martine Extermann
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
| | | | - Claudine Isaacs
- Departments of Oncology and Medicine, Breast Cancer Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Paul B Jacobsen
- Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
| | - Heather Jim
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
- Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Zev M Nakamura
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Sunita K Patel
- Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - Kelly Rentscher
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human BehaviorJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Kathleen Van Dyk
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human BehaviorJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA
| | - Jeanne S Mandelblatt
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Tim A Ahles
- Neurocognitive Research Lab, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Avenue, 7th Floor, New York, NY, USA
| |
Collapse
|
24
|
Ferguson RJ, McDonald BC, Terhorst L, Gibbons B, Zhao S, Bailey J, Kreitz A. Telehealth cognitive-behavioral therapy for cancer-related cognitive impairment: A model for remote clinical trial participation. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.tps12143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
TPS12143 Background: Cancer-related cognitive impairment (CRCI) can include persistent memory symptoms, and affects many cancer survivors. Memory and Attention Adaptation Training (MAAT) is an evidence-based cognitive behavioral therapy (CBT) that improves CRCI with demonstrated efficacy in telehealth delivery. MAAT consists of 8 weekly (45-minute) video visits. The aims of this study are to confirm MAAT telehealth efficacy in a phase III RCT (MAAT versus Supportive Therapy; ST) across large catchment areas of two comprehensive cancer centers. A secondary aim is to evaluate treatment-induced brain activation as assessed by functional MRI (fMRI) in a subset of participants. We present remote treatment and data capture methods of this open NCI-sponsored (R01CA244673) randomized clinical trial (NCT 04586530). These methods have high success in participant accrual despite COVID-19 pandemic conditions, and can be readily adopted to other clinical trials to enhance rural/underserved enrollment. Methods: We are enrolling 200 adult, stage I-III breast cancer survivors 1-5 years post-chemotherapy with cognitive complaints. Individuals with CNS disease, previous brain injury, dementia or psychiatric disorder are excluded. All study procedures are completed from the participant’s home (except fMRI). Eligibility screening is a semi-structured phone interview followed by detailed informed consent online (Research Electronic Data Capture: REDCap) with staff phone guidance. Consented participants complete baseline brief phone-based neurocognitive assessment and validated patient-reported outcome measures (PROs) of cognition and quality of life via REDCap. Participants are randomized to MAAT or ST and assigned treating clinicians at respective cancer centers. All 8 visits are completed through secure telehealth platforms, followed by repeat phone/online assessment post-treatment and again at 6 months. Enrollment began in 3/2021. As of 1/2022 (9 months), 56 participants are enrolled (28% of the planned sample), 47 randomized (MAAT 24; ST 23), with 24 completing post-treatment assessments. If all assessments and treatment visits were in person, travel burden per participant is 968 miles/20.5 hours driven, and $542 (US 2021 Federal rate). Thus, study travel savings to date are $30,352. Participant feedback indicates telehealth makes participation possible, similar to previous MAAT research. The current RCT demonstrates utility, efficiency and cost-savings of telehealth and remote data capture technology in the conduct of cancer control research. Elements of methods described can also be adopted for cancer therapeutic trials. Comprehensive cancer centers, where most clinical trials are based, can enhance participation of remote and/or underserved populations that have higher rates of cancer, more disease burden and less opportunity for trial participation. Clinical trial information: NCT04586530.
Collapse
|
25
|
Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, Cohen HJ, Graham D, Extermann M, Heutte N, Jim HSL, McDonald BC, Patel SK, Root JC, Saykin AJ, Van Dyk K, Zhou X, Mandelblatt J, Joly F. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Res Treat 2022; 191:459-469. [PMID: 34817750 PMCID: PMC8766903 DOI: 10.1007/s10549-021-06455-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Accepted: 11/14/2021] [Indexed: 01/03/2023]
Abstract
PURPOSE Older cancer patients are susceptible to long-term effects of chemotherapy, including cancer-related cognitive decline and impairments to quality of life. Taxane-based chemotherapies are associated with physical declines among older women and may negatively impact cognitive performance. We sought to examine whether changes in objective and subjective measures of cognitive performance and well-being differ among older breast cancer survivors as a function of taxane-based chemotherapy treatment regimens. METHODS Individual-level data were pooled and harmonized from two large prospective studies of older (greater than 60 years) breast cancer survivors. Assessments were conducted prior to systemic therapy and up to 36 months after. Cognitive performance was assessed with objective (working memory, processing speed, and executive functions) and subjective tests and physical, emotional, and functional well-being were also assessed. RESULTS One hundred and sixty-seven (M age = 67.3 years) women with 116 receiving chemotherapy with taxanes and 51 without taxanes contributed data. Declines in subjective cognition for both groups were significant between pre-treatment and 12-month follow-up. Significant improvements were seen on a measure of objective cognition (working memory) from 12 to 36 months. Measures of well-being improved from prior to systemic therapy to 12 months. Longitudinal changes across all measures did not vary as a function of receipt of taxane-based treatment. CONCLUSION Older women who received treatment with taxanes did not have greater declines in cognitive performance or well-being than women receiving other chemotherapy regimens. Despite older cancer survivors being at greater risk for negative outcomes, treatment with taxane-based chemotherapies does not appear to exacerbate these health consequences.
Collapse
Affiliation(s)
- Brent J Small
- School of Aging Studies, University of South Florida, 13301 Bruce B. Downs Blvd, Tampa, FL, 33620, USA.
| | - Marie Lange
- Medical Oncology Department, Centre François Baclesse, and Normandie University, UNICAEN, INSERM, ANTICIPE, and Cancer and Cognition Platform, Ligue Nationale Contre le Cancer, Caen, France
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
| | - Judith E Carroll
- UCLA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center and Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
| | - Harvey J Cohen
- Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, NC, USA
| | | | - Martine Extermann
- Department of Oncology Sciences, Senior Adult Oncology Program, Moffitt Cancer Center, Tampa, FL, USA
| | - Natacha Heutte
- Department of Clinical Research, Center François Baclesse, and Normandie Université, Caen, France
| | - Heather S L Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine and the Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA
| | - Sunita K Patel
- Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine and the Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA
| | - Kathleen Van Dyk
- Department of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, UCLA, Semel Institute, Los Angeles, CA, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Jeanne Mandelblatt
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Florence Joly
- Medical Oncology Department, Centre François Baclesse, and Normandie University, UNICAEN, INSERM, ANTICIPE, and Cancer and Cognition Platform, Ligue Nationale Contre le Cancer, Caen, France
| |
Collapse
|
26
|
Dima D, Modabbernia A, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes‐Eizagirre A, Alnæs D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur‐Streubel R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Buckner RL, Calhoun V, Canales‐Rodríguez EJ, Cannon DM, Caseras X, Castellanos FX, Cervenka S, Chaim‐Avancini TM, Ching CRK, Chubar V, Clark VP, Conrod P, Conzelmann A, Crespo‐Facorro B, Crivello F, Crone EA, Dannlowski U, Dale AM, Davey C, de Geus EJC, de Haan L, de Zubicaray GI, den Braber A, Dickie EW, Di Giorgio A, Doan NT, Dørum ES, Ehrlich S, Erk S, Espeseth T, Fatouros‐Bergman H, Fisher SE, Fouche J, Franke B, Frodl T, Fuentes‐Claramonte P, Glahn DC, Gotlib IH, Grabe H, Grimm O, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Gur RE, Gur RC, Hahn T, Harrison BJ, Hartman CA, Hatton SN, Heinz A, Heslenfeld DJ, Hibar DP, Hickie IB, Ho B, Hoekstra PJ, Hohmann S, Holmes AJ, Hoogman M, Hosten N, Howells FM, Hulshoff Pol HE, Huyser C, Jahanshad N, James A, Jernigan TL, Jiang J, Jönsson EG, Joska JA, Kahn R, Kalnin A, Kanai R, Klein M, Klyushnik TP, Koenders L, Koops S, Krämer B, Kuntsi J, Lagopoulos J, Lázaro L, Lebedeva I, Lee WH, Lesch K, Lochner C, Machielsen MWJ, Maingault S, Martin NG, Martínez‐Zalacaín I, Mataix‐Cols D, Mazoyer B, McDonald C, McDonald BC, McIntosh AM, McMahon KL, McPhilemy G, Meinert S, Menchón JM, Medland SE, Meyer‐Lindenberg A, Naaijen J, Najt P, Nakao T, Nordvik JE, Nyberg L, Oosterlaan J, de la Foz VO, Paloyelis Y, Pauli P, Pergola G, Pomarol‐Clotet E, Portella MJ, Potkin SG, Radua J, Reif A, Rinker DA, Roffman JL, Rosa PGP, Sacchet MD, Sachdev PS, Salvador R, Sánchez‐Juan P, Sarró S, Satterthwaite TD, Saykin AJ, Serpa MH, Schmaal L, Schnell K, Schumann G, Sim K, Smoller JW, Sommer I, Soriano‐Mas C, Stein DJ, Strike LT, Swagerman SC, Tamnes CK, Temmingh HS, Thomopoulos SI, Tomyshev AS, Tordesillas‐Gutiérrez D, Trollor JN, Turner JA, Uhlmann A, van den Heuvel OA, van den Meer D, van der Wee NJA, van Haren NEM, van't Ent D, van Erp TGM, Veer IM, Veltman DJ, Voineskos A, Völzke H, Walter H, Walton E, Wang L, Wang Y, Wassink TH, Weber B, Wen W, West JD, Westlye LT, Whalley H, Wierenga LM, Williams SCR, Wittfeld K, Wolf DH, Worker A, Wright MJ, Yang K, Yoncheva Y, Zanetti MV, Ziegler GC, Thompson PM, Frangou S. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. Hum Brain Mapp 2022; 43:452-469. [PMID: 33570244 PMCID: PMC8675429 DOI: 10.1002/hbm.25320] [Citation(s) in RCA: 42] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 11/27/2020] [Accepted: 12/06/2020] [Indexed: 12/25/2022] Open
Abstract
Age has a major effect on brain volume. However, the normative studies available are constrained by small sample sizes, restricted age coverage and significant methodological variability. These limitations introduce inconsistencies and may obscure or distort the lifespan trajectories of brain morphometry. In response, we capitalized on the resources of the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to examine age-related trajectories inferred from cross-sectional measures of the ventricles, the basal ganglia (caudate, putamen, pallidum, and nucleus accumbens), the thalamus, hippocampus and amygdala using magnetic resonance imaging data obtained from 18,605 individuals aged 3-90 years. All subcortical structure volumes were at their maximum value early in life. The volume of the basal ganglia showed a monotonic negative association with age thereafter; there was no significant association between age and the volumes of the thalamus, amygdala and the hippocampus (with some degree of decline in thalamus) until the sixth decade of life after which they also showed a steep negative association with age. The lateral ventricles showed continuous enlargement throughout the lifespan. Age was positively associated with inter-individual variability in the hippocampus and amygdala and the lateral ventricles. These results were robust to potential confounders and could be used to examine the functional significance of deviations from typical age-related morphometric patterns.
Collapse
Affiliation(s)
- Danai Dima
- Department of Psychology, School of Arts and Social SciencesCity University of LondonLondonUK
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | | | | | | | - Ingrid Agartz
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
| | - Moji Aghajani
- Department of Psychiatry, Amsterdam University Medical CentreLocation VUmcAmsterdamNetherlands
- Institute of Education & Child StudiesSection Forensic Family & Youth Care, Leiden UniversityNetherlands
| | - Theophilus N. Akudjedu
- Institute of Medical Imaging and Visualisation, Department of Medical Science and Public Health, Faculty of Health and Social SciencesBournemouth UniversityPooleUK
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandDublinIreland
| | - Anton Albajes‐Eizagirre
- FIDMAG Germanes HospitalàriesMadridSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - Dag Alnæs
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
| | | | - Micael Andersson
- Department of Integrative Medical BiologyUmeå UniversityUmeåSweden
| | - Nancy C. Andreasen
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Ole A. Andreassen
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
| | - Philip Asherson
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityMannheimGermany
| | - Nuria Bargallo
- Imaging Diagnostic Centre, Hospital ClinicBarcelona University ClinicBarcelonaSpain
- August Pi i Sunyer Biomedical Research Institut (IDIBAPS)BarcelonaSpain
| | - Sarah Baumeister
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityMannheimGermany
| | - Ramona Baur‐Streubel
- Department of Psychology, Biological Psychology, Clinical Psychology and PsychotherapyUniversity of WürzburgWurzburgGermany
| | - Alessandro Bertolino
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Aurora Bonvino
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Dorret I. Boomsma
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Stefan Borgwardt
- Department of Psychiatry & PsychotherapyUniversity of LübeckLubeckGermany
| | - Josiane Bourque
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Daniel Brandeis
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityMannheimGermany
| | - Alan Breier
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyAustralia
| | - Rachel M. Brouwer
- Rudolf Magnus Institute of NeuroscienceUniversity Medical Center UtrechtUtrechtNetherlands
| | - Jan K. Buitelaar
- Donders Center of Medical NeurosciencesRadboud UniversityNijmegenNetherlands
- Donders Centre for Cognitive NeuroimagingRadboud UniversityNijmegenNetherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
| | - Geraldo F. Busatto
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Randy L. Buckner
- Department of Psychology, Center for Brain ScienceHarvard UniversityCambridgeMassachusettsUSA
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
| | - Vincent Calhoun
- Tri‐Institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, USA Neurology, Radiology, Psychiatry and Biomedical EngineeringEmory UniversityAtlantaGeorgiaUSA
| | | | - Dara M. Cannon
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandDublinIreland
| | - Xavier Caseras
- MRC Centre for Neuropsychiatric Genetics and GenomicsCardiff UniversityCardiffUK
| | | | - Simon Cervenka
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
- Stockholm Health Care ServicesStockholm RegionStockholmSweden
| | - Tiffany M. Chaim‐Avancini
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Christopher R. K. Ching
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Victoria Chubar
- Department of NeuroscienceKU Leuven, Mind‐Body Research GroupLeuvenBelgium
| | - Vincent P. Clark
- Department of PsychologyUniversity of New MexicoAlbuquerqueNew MexicoUSA
- Mind Research NetworkAlbuquerqueNew MexicoUSA
| | - Patricia Conrod
- Department of PsychiatryUniversité de MontréalMontrealCanada
| | - Annette Conzelmann
- Department of Child and Adolescent Psychiatry, Psychosomatics and PsychotherapyUniversity of TübingenTubingenGermany
| | - Benedicto Crespo‐Facorro
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- HU Virgen del Rocio, IBiS, University of SevillaSevillaSpain
| | - Fabrice Crivello
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxTalenceFrance
| | - Eveline A. Crone
- Erasmus School of Social and Behavioural SciencesErasmus University RotterdamRotterdamNetherlands
- Faculteit der Sociale Wetenschappen, Instituut PsychologieUniversiteit LeidenLeidenNetherlands
| | - Udo Dannlowski
- Department of Psychiatry and PsychotherapyUniversity of MünsterMunsterGermany
| | - Anders M. Dale
- Center for Multimodal Imaging and Genetics, Department of Neuroscience and Department of RadiologyUniversity of California‐San DiegoLa JollaCaliforniaUSA
| | | | - Eco J. C. de Geus
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Lieuwe de Haan
- Academisch Medisch CentrumUniversiteit van AmsterdamAmsterdamNetherlands
| | - Greig I. de Zubicaray
- Faculty of Health, Institute of Health and Biomedical InnovationQueensland University of TechnologyBrisbaneAustralia
| | - Anouk den Braber
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Erin W. Dickie
- Kimel Family Translational Imaging Genetics LaboratoryCampbell Family Mental Health Research Institute, CAMHTorontoCanada
- Department of PsychiatryUniversity of TorontoTorontoCanada
| | - Annabella Di Giorgio
- Biological Psychiatry Lab, Fondazione IRCCS Casa Sollievo della SofferenzaSan Giovanni Rotondo (FG)Italy
| | - Nhat Trung Doan
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
| | - Erlend S. Dørum
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Department of PsychologyUniversity of OsloOsloNorway
- Sunnaas Rehabilitation Hospital HTNesoddenNorway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental NeurosciencesTechnische Universität DresdenDresdenGermany
- Faculty of MedicineUniversitätsklinikum Carl Gustav Carus an der TU DresdenDresdenGermany
| | - Susanne Erk
- Division of Mind and Brain Research, Department of Psychiatry and PsychotherapyCharité‐Universitätsmedizin BerlinBerlinGermany
| | - Thomas Espeseth
- Department of PsychologyUniversity of OsloOsloNorway
- Bjørknes CollegeOsloNorway
| | - Helena Fatouros‐Bergman
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
- Stockholm Health Care ServicesStockholm RegionStockholmSweden
| | - Simon E. Fisher
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
| | - Jean‐Paul Fouche
- Department of Psychiatry and Mental HealthUniversity of Cape TownRondeboschSouth Africa
| | - Barbara Franke
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenNetherlands
- Department of PsychiatryRadboud University Medical CenterNijmegenNetherlands
| | - Thomas Frodl
- Department of Psychiatry and PsychotherapyOtto von Guericke University MagdeburgMagdeburgGermany
| | - Paola Fuentes‐Claramonte
- FIDMAG Germanes HospitalàriesMadridSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - David C. Glahn
- Department of Psychiatry, Tommy Fuss Center for Neuropsychiatric Disease Research Boston Children's HospitalHarvard Medical SchoolBostonMassachusettsUSA
| | - Ian H. Gotlib
- Department of PsychologyStanford UniversityStanfordCaliforniaUSA
| | - Hans‐Jörgen Grabe
- Department of Psychiatry and PsychotherapyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Oliver Grimm
- Department for Psychiatry, Psychosomatics and Psychotherapy, Universitätsklinikum FrankfurtGoethe UniversitatFrankfurtGermany
| | - Nynke A. Groenewold
- Department of Psychiatry and Mental HealthUniversity of Cape TownRondeboschSouth Africa
- Neuroscience InstituteUniversity of Cape TownRondeboschSouth Africa
| | | | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg UniversityHeidelbergGermany
| | - Patricia Gruner
- Department of PsychiatryYale UniversityNew HavenConnecticutUSA
- Learning Based Recovery CenterVA Connecticut Health SystemNew HavenConnecticutUSA
| | - Rachel E. Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Lifespan Brain Institute, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Children's Hospital of PhiladelphiaUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Ruben C. Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Lifespan Brain Institute, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Children's Hospital of PhiladelphiaUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Tim Hahn
- Department of Psychiatry and PsychotherapyUniversity of MünsterMunsterGermany
| | - Ben J. Harrison
- Melbourne Neuropsychiatry CenterUniversity of MelbourneMelbourneAustralia
| | - Catharine A. Hartman
- Interdisciplinary Center Psychopathology and Emotion regulationUniversity Medical Center Groningen, University of GroningenGroningenNetherlands
| | - Sean N. Hatton
- Brain and Mind CentreUniversity of SydneySydneyAustralia
| | - Andreas Heinz
- Faculty of MedicineUniversitätsklinikum Carl Gustav Carus an der TU DresdenDresdenGermany
| | - Dirk J. Heslenfeld
- Departments of Experimental and Clinical PsychologyVrije Universiteit AmsterdamAmsterdamNetherlands
| | - Derrek P. Hibar
- Personalized HealthcareGenentech, IncSouth San FranciscoCaliforniaUSA
| | - Ian B. Hickie
- Brain and Mind CentreUniversity of SydneySydneyAustralia
| | - Beng‐Choon Ho
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Pieter J. Hoekstra
- Department of PsychiatryUniversity Medical Center Groningen, University of GroningenGroningenNetherlands
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityMannheimGermany
| | - Avram J. Holmes
- Department of PsychologyYale UniversityNew HavenConnecticutUSA
| | - Martine Hoogman
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Psychiatry and Mental HealthUniversity of Cape TownRondeboschSouth Africa
| | - Norbert Hosten
- Norbert Institute of Diagnostic Radiology and NeuroradiologyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
| | - Fleur M. Howells
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
- Department for Psychiatry, Psychosomatics and Psychotherapy, Universitätsklinikum FrankfurtGoethe UniversitatFrankfurtGermany
| | | | - Chaim Huyser
- Bascule, Academic Centre for Children and Adolescent PsychiatryDuivendrechtNetherlands
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | | | - Terry L. Jernigan
- Center for Human Development, Departments of Cognitive Science, Psychiatry, and RadiologyUniversity of CaliforniaSan DiegoCaliforniaUSA
| | - Jiyang Jiang
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyAustralia
| | - Erik G. Jönsson
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
- Stockholm Health Care ServicesStockholm RegionStockholmSweden
| | - John A. Joska
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
| | - Rene Kahn
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Andrew Kalnin
- Department of RadiologyOhio State University College of MedicineColumbusOhioUSA
| | - Ryota Kanai
- Department of NeuroinformaticsAraya, IncTokyoJapan
| | - Marieke Klein
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Psychiatry and Mental HealthUniversity of Cape TownRondeboschSouth Africa
- Department of PsychiatryUniversity of California San DiegoLa JollaCaliforniaUSA
| | | | - Laura Koenders
- Department of PsychiatryUniversity of MelbourneMelbourneAustralia
| | - Sanne Koops
- Rudolf Magnus Institute of NeuroscienceUniversity Medical Center UtrechtUtrechtNetherlands
| | - Bernd Krämer
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg UniversityHeidelbergGermany
| | - Jonna Kuntsi
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Jim Lagopoulos
- Sunshine Coast Mind and Neuroscience, Thompson InstituteUniversity of the Sunshine CoastSunshine CoastAustralia
| | - Luisa Lázaro
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of Child and Adolescent Psychiatry and PsychologyHospital Clinic, University of BarcelonaBarcelonaSpain
| | - Irina Lebedeva
- Mental Health Research CenterRussian Academy of Medical SciencesMoskvaRussia
| | - Won Hee Lee
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
| | - Klaus‐Peter Lesch
- Department of Psychiatry, Psychosomatics and PsychotherapyJulius‐Maximilians Universität WürzburgWurzburgGermany
| | - Christine Lochner
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of PsychiatryStellenbosch UniversityStellenboschSouth Africa
| | | | - Sophie Maingault
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxTalenceFrance
| | - Nicholas G. Martin
- Queensland Institute of Medical ResearchBerghofer Medical Research InstituteBrisbaneAustralia
| | - Ignacio Martínez‐Zalacaín
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - David Mataix‐Cols
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
- Stockholm Health Care ServicesStockholm RegionStockholmSweden
| | - Bernard Mazoyer
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxTalenceFrance
| | - Colm McDonald
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandDublinIreland
| | - Brenna C. McDonald
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | | | - Katie L. McMahon
- School of Clinical Sciences, Institute of Health and Biomedical InnovationQueensland University of TechnologyBrisbaneAustralia
| | - Genevieve McPhilemy
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandDublinIreland
| | - Susanne Meinert
- Department of Psychiatry and PsychotherapyUniversity of MünsterMunsterGermany
| | - José M. Menchón
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - Sarah E. Medland
- Queensland Institute of Medical ResearchBerghofer Medical Research InstituteBrisbaneAustralia
| | - Andreas Meyer‐Lindenberg
- Department of Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityHeidelbergGermany
| | - Jilly Naaijen
- Donders Centre for Cognitive NeuroimagingRadboud UniversityNijmegenNetherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
| | - Pablo Najt
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandDublinIreland
| | - Tomohiro Nakao
- Department of Clinical MedicineKyushu UniversityKyushuJapan
| | | | - Lars Nyberg
- Department of Integrative Medical BiologyUmeå UniversityUmeåSweden
- Department of Radiation Sciences, Umeå Center for Functional Brain ImagingUmeå UniversityUmeåSweden
| | - Jaap Oosterlaan
- Department of Clinical NeuropsychologyAmsterdam University Medical Centre, Vrije Universiteit AmsterdamAmsterdamNetherlands
| | - Víctor Ortiz‐García de la Foz
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of Psychiatry, University Hospital “Marques de Valdecilla”Instituto de Investigación Valdecilla (IDIVAL)SantanderSpain
- Instituto de Salud Carlos IIIMadridSpain
| | - Yannis Paloyelis
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Paul Pauli
- Department of Psychology, Biological Psychology, Clinical Psychology and PsychotherapyUniversity of WürzburgWurzburgGermany
- Centre of Mental HealthUniversity of WürzburgWurzburgGermany
| | - Giulio Pergola
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Edith Pomarol‐Clotet
- FIDMAG Germanes HospitalàriesMadridSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - Maria J. Portella
- FIDMAG Germanes HospitalàriesMadridSpain
- Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant PauUniversitat Autònoma de BarcelonaBarcelonaSpain
| | - Steven G. Potkin
- Department of PsychiatryUniversity of California at IrvineIrvineCaliforniaUSA
| | - Joaquim Radua
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetStockholmSweden
- August Pi i Sunyer Biomedical Research Institut (IDIBAPS)BarcelonaSpain
- Department of Psychosis Studies, Institute of PsychiatryPsychology & Neuroscience, King's College LondonLondonUK
| | - Andreas Reif
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Daniel A. Rinker
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
| | - Joshua L. Roffman
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
| | - Pedro G. P. Rosa
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Matthew D. Sacchet
- Center for Depression, Anxiety, and Stress ResearchMcLean Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyAustralia
| | | | - Pascual Sánchez‐Juan
- Department of Psychiatry, University Hospital “Marques de Valdecilla”Instituto de Investigación Valdecilla (IDIVAL)SantanderSpain
- Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)MadridSpain
| | | | | | - Andrew J. Saykin
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Mauricio H. Serpa
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental HealthParkvilleAustralia
- Centre for Youth Mental HealthThe University of MelbourneMelbourneAustralia
| | - Knut Schnell
- Department of Psychiatry and PsychotherapyUniversity Medical Center GöttingenGöttingenGermany
| | - Gunter Schumann
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
- Centre for Population Neuroscience and Precision Medicine, Institute of PsychiatryPsychology & Neuroscience, King's College LondonLondonUK
| | - Kang Sim
- Institute of Mental HealthSingaporeSingapore
| | - Jordan W. Smoller
- Center for Genomic MedicineMassachusetts General HospitalBostonMassachusettsUSA
| | - Iris Sommer
- Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit GroningenUniversity Medical Center GroningenGöttingenNetherlands
| | - Carles Soriano‐Mas
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - Dan J. Stein
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of PsychiatryStellenbosch UniversityStellenboschSouth Africa
| | | | | | - Christian K. Tamnes
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- PROMENTA Research Center, Department of PsychologyUniversity of OsloOsloNorway
| | - Henk S. Temmingh
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
| | - Sophia I. Thomopoulos
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | | | - Diana Tordesillas‐Gutiérrez
- FIDMAG Germanes HospitalàriesMadridSpain
- Neuroimaging Unit, Technological FacilitiesValdecilla Biomedical Research Institute IDIVALSantanderSpain
| | - Julian N. Trollor
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyAustralia
| | - Jessica A. Turner
- College of Arts and SciencesGeorgia State UniversityAtlantaGeorgiaUSA
| | - Anne Uhlmann
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
| | - Odile A. van den Heuvel
- Department of Psychiatry, Amsterdam University Medical CentreLocation VUmcAmsterdamNetherlands
| | - Dennis van den Meer
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical MedicineUniversity of OsloOsloNorway
- Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life SciencesMaastricht UniversityMaastrichtNetherlands
| | - Nic J. A. van der Wee
- Department of PsychiatryLeiden University Medical CenterLeidenNetherlands
- Leiden Institute for Brain and CognitionLeidenNetherlands
| | - Neeltje E. M. van Haren
- Department of Child and Adolescent Psychiatry/PsychologyErasmus University Medical Center, Sophia Children's HospitalRotterdamThe Netherlands
| | - Dennis van't Ent
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Theo G. M. van Erp
- Department of PsychiatryUniversity of California at IrvineIrvineCaliforniaUSA
- Center for the Neurobiology of Learning and MemoryUniversity of California IrvineIrvineCaliforniaUSA
- Institute of Community MedicineUniversity Medicine, Greifswald, University of GreifswaldGreifswaldGermany
| | - Ilya M. Veer
- Faculty of MedicineUniversitätsklinikum Carl Gustav Carus an der TU DresdenDresdenGermany
| | - Dick J. Veltman
- Department of Psychiatry, Amsterdam University Medical CentreLocation VUmcAmsterdamNetherlands
| | - Aristotle Voineskos
- Faculty of Health, Institute of Health and Biomedical InnovationQueensland University of TechnologyBrisbaneAustralia
- Kimel Family Translational Imaging Genetics LaboratoryCampbell Family Mental Health Research Institute, CAMHTorontoCanada
| | - Henry Völzke
- Institute of Community MedicineUniversity Medicine, Greifswald, University of GreifswaldGreifswaldGermany
- German Centre for Cardiovascular Research (DZHK), partner site GreifswaldGreifswaldGermany
- German Center for Diabetes Research (DZD), partner site GreifswaldGreifswaldGermany
| | - Henrik Walter
- Faculty of MedicineUniversitätsklinikum Carl Gustav Carus an der TU DresdenDresdenGermany
| | | | - Lei Wang
- Department of Psychiatry and Behavioral Sciences, Feinberg School of MedicineNorthwestern UniversityChicagoIllinoisUSA
| | - Yang Wang
- Department of RadiologyMedical College of WisconsinMilwaukeeWisconsinUSA
| | - Thomas H. Wassink
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Bernd Weber
- Institute for Experimental Epileptology and Cognition ResearchUniversity of BonnBonnGermany
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyAustralia
| | - John D. West
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Lars T. Westlye
- Biological Psychiatry Lab, Fondazione IRCCS Casa Sollievo della SofferenzaSan Giovanni Rotondo (FG)Italy
| | | | - Lara M. Wierenga
- Developmental and Educational Psychology UnitInstitute of Psychology, Leiden UniversityLeidenNetherlands
| | - Steven C. R. Williams
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Katharina Wittfeld
- Department of PsychologyStanford UniversityStanfordCaliforniaUSA
- Department of Psychiatry and PsychotherapyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
| | - Daniel H. Wolf
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Amanda Worker
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | | | - Kun Yang
- National High Magnetic Field LaboratoryFlorida State UniversityTallahasseeFloridaUSA
| | - Yulyia Yoncheva
- Department of Child and Adolescent PsychiatryChild Study Center, NYU Langone HealthNew YorkNew YorkUSA
| | - Marcus V. Zanetti
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
- Instituto de Ensino e Pesquisa, Hospital Sírio‐LibanêsSão PauloBrazil
| | - Georg C. Ziegler
- Division of Molecular Psychiatry, Center of Mental HealthUniversity of WürzburgWurzburgGermany
| | - Paul M. Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Sophia Frangou
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Department of Psychiatry, Djavad Mowafaghian Centre for Brain HealthUniversity of British ColumbiaVancouverCanada
| | | |
Collapse
|
27
|
Wierenga LM, Doucet GE, Dima D, Agartz I, Aghajani M, Akudjedu TN, Albajes‐Eizagirre A, Alnæs D, Alpert KI, Andreassen OA, Anticevic A, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur‐Streubel R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, den Braber A, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Calhoun VD, Canales‐Rodríguez EJ, Cannon DM, Caseras X, Castellanos FX, Chaim‐Avancini TM, Ching CRK, Clark VP, Conrod PJ, Conzelmann A, Crivello F, Davey CG, Dickie EW, Ehrlich S, van't Ent D, Fisher SE, Fouche J, Franke B, Fuentes‐Claramonte P, de Geus EJC, Di Giorgio A, Glahn DC, Gotlib IH, Grabe HJ, Gruber O, Gruner P, Gur RE, Gur RC, Gurholt TP, de Haan L, Haatveit B, Harrison BJ, Hartman CA, Hatton SN, Heslenfeld DJ, van den Heuvel OA, Hickie IB, Hoekstra PJ, Hohmann S, Holmes AJ, Hoogman M, Hosten N, Howells FM, Hulshoff Pol HE, Huyser C, Jahanshad N, James AC, Jiang J, Jönsson EG, Joska JA, Kalnin AJ, Klein M, Koenders L, Kolskår KK, Krämer B, Kuntsi J, Lagopoulos J, Lazaro L, Lebedeva IS, Lee PH, Lochner C, Machielsen MWJ, Maingault S, Martin NG, Martínez‐Zalacaín I, Mataix‐Cols D, Mazoyer B, McDonald BC, McDonald C, McIntosh AM, McMahon KL, McPhilemy G, van der Meer D, Menchón JM, Naaijen J, Nyberg L, Oosterlaan J, Paloyelis Y, Pauli P, Pergola G, Pomarol‐Clotet E, Portella MJ, Radua J, Reif A, Richard G, Roffman JL, Rosa PGP, Sacchet MD, Sachdev PS, Salvador R, Sarró S, Satterthwaite TD, Saykin AJ, Serpa MH, Sim K, Simmons A, Smoller JW, Sommer IE, Soriano‐Mas C, Stein DJ, Strike LT, Szeszko PR, Temmingh HS, Thomopoulos SI, Tomyshev AS, Trollor JN, Uhlmann A, Veer IM, Veltman DJ, Voineskos A, Völzke H, Walter H, Wang L, Wang Y, Weber B, Wen W, West JD, Westlye LT, Whalley HC, Williams SCR, Wittfeld K, Wolf DH, Wright MJ, Yoncheva YN, Zanetti MV, Ziegler GC, de Zubicaray GI, Thompson PM, Crone EA, Frangou S, Tamnes CK. Greater male than female variability in regional brain structure across the lifespan. Hum Brain Mapp 2022; 43:470-499. [PMID: 33044802 PMCID: PMC8675415 DOI: 10.1002/hbm.25204] [Citation(s) in RCA: 42] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 08/10/2020] [Accepted: 09/05/2020] [Indexed: 12/25/2022] Open
Abstract
For many traits, males show greater variability than females, with possible implications for understanding sex differences in health and disease. Here, the ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis) Consortium presents the largest-ever mega-analysis of sex differences in variability of brain structure, based on international data spanning nine decades of life. Subcortical volumes, cortical surface area and cortical thickness were assessed in MRI data of 16,683 healthy individuals 1-90 years old (47% females). We observed significant patterns of greater male than female between-subject variance for all subcortical volumetric measures, all cortical surface area measures, and 60% of cortical thickness measures. This pattern was stable across the lifespan for 50% of the subcortical structures, 70% of the regional area measures, and nearly all regions for thickness. Our findings that these sex differences are present in childhood implicate early life genetic or gene-environment interaction mechanisms. The findings highlight the importance of individual differences within the sexes, that may underpin sex-specific vulnerability to disorders.
Collapse
Affiliation(s)
- Lara M Wierenga
- Institute of PsychologyLeiden UniversityLeidenThe Netherlands
- Leiden Institute for Brain and CognitionLeidenThe Netherlands
| | - Gaelle E Doucet
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Boys Town National Research HospitalOmahaNebraskaUSA
| | - Danai Dima
- Department of Psychology, School of Arts and Social Sciences, CityUniversity of LondonLondonUK
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Ingrid Agartz
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care ServicesStockholm County CouncilStockholmSweden
| | - Moji Aghajani
- Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMCVrije UniversiteitAmsterdamThe Netherlands
- Department of Research & InnovationGGZ inGeestAmsterdamThe Netherlands
- Institute of Education and Child Studies, Forensic Family and Youth CareLeiden UniversityLeidenThe Netherlands
| | - Theophilus N Akudjedu
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health SciencesNational University of Ireland GalwayGalwayIreland
- Institute of Medical Imaging & Visualisation, Faculty of Health & Social SciencesBournemouth UniversityBournemouthUK
| | - Anton Albajes‐Eizagirre
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)BarcelonaSpain
| | - Dag Alnæs
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
| | - Kathryn I Alpert
- Department of Psychiatry and Behavioral SciencesNorthwestern University Feinberg School of MedicineChicagoIllinoisUSA
| | - Ole A Andreassen
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
| | - Alan Anticevic
- Department of PsychiatryYale UniversityNew HavenConnecticutUSA
| | - Philip Asherson
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthUniversity of Heidelberg, Medical Faculty MannheimMannheimGermany
| | - Nuria Bargallo
- Imaging Diagnostic CenterHospital ClínicBarcelonaSpain
- Magnetic Resonance Image Core FacilityIDIBAPSBarcelonaSpain
| | - Sarah Baumeister
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthUniversity of Heidelberg, Medical Faculty MannheimMannheimGermany
| | | | - Alessandro Bertolino
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Aurora Bonvino
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Dorret I Boomsma
- Department of Biological PsychologyVU University AmsterdamAmsterdamThe Netherlands
| | - Stefan Borgwardt
- Department of PsychiatryUniversity of BaselBaselSwitzerland
- Department of PsychiatryUniversity of LübeckLübeckGermany
| | - Josiane Bourque
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- CHU Sainte‐Justine Research CenterMontrealQuebecCanada
| | - Anouk den Braber
- Department of Biological PsychologyVU University AmsterdamAmsterdamThe Netherlands
- Alzheimer CenterAmsterdam UMC, Location VUMCAmsterdamThe Netherlands
| | - Daniel Brandeis
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthUniversity of Heidelberg, Medical Faculty MannheimMannheimGermany
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric HospitalUniversity of ZurichZurichSwitzerland
- Zurich Center for Integrative Human PhysiologyUniversity of ZurichZurichSwitzerland
- Neuroscience Centre ZurichUniversity and ETH ZurichZurichSwitzerland
| | - Alan Breier
- Department of PsychiatryIndiana University School of MedicineIndianapolisIndianaUSA
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
- Dementia Centre for Research Collaboration, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
| | - Rachel M Brouwer
- Department of Psychiatry, University Medical Center Utrecht Brain CenterUtrecht UniversityUtrechtThe Netherlands
| | - Jan K Buitelaar
- Department of Cognitive NeuroscienceRadboud University Medical CentreNijmegenThe Netherlands
- Karakter Child and Adolescent Psychiatry University CentreNijmegenThe Netherlands
| | - Geraldo F Busatto
- Laboratory of Psychiatric Neuroimaging (LIM‐21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Vince D Calhoun
- Tri‐institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS)Georgia State, Georgia TechAtlantaGeorgiaUSA
| | - Erick J Canales‐Rodríguez
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
| | - Dara M Cannon
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health SciencesNational University of Ireland GalwayGalwayIreland
| | - Xavier Caseras
- MRC Centre for Neuropsychiatric Genetics and GenomicsCardiff UniversityCardiffUK
| | - Francisco X Castellanos
- Department of Child and Adolescent PsychiatryNYU Grossman School of MedicineNew YorkNew YorkUSA
- Nathan Kline Institute for Psychiatric ResearchOrangeburgNew YorkUSA
| | - Tiffany M Chaim‐Avancini
- Laboratory of Psychiatric Neuroimaging (LIM‐21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Christopher RK Ching
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Vincent P Clark
- Psychology Clinical Neuroscience Center, Department of PsychologyUniversity of New MexicoAlbuquerqueNew MexicoUSA
- Mind Research NetworkAlbuquerqueNew MexicoUSA
| | - Patricia J Conrod
- CHU Sainte‐Justine Research CenterMontrealQuebecCanada
- Department of PsychiatryUniversity of MontrealMontrealCanada
| | - Annette Conzelmann
- Department of Child and Adolescent Psychiatry, Psychosomatics and PsychotherapyUniversity of TübingenTübingenGermany
- Department of Psychology (Clinical Psychology II)PFH – Private University of Applied SciencesGöttingenGermany
| | - Fabrice Crivello
- Groupe d'Imagerie NeurofonctionnelleInstitut des Maladies NeurodégénérativesBordeauxFrance
| | - Christopher G Davey
- Centre for Youth Mental HealthUniversity of MelbourneParkvilleVictoriaAustralia
- OrygenParkvilleVictoriaAustralia
| | - Erin W Dickie
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of PsychiatryUniversity of TorontoTorontoCanada
- Department of PsychiatryUniversity of TorontoTorontoOntarioCanada
| | - Stefan Ehrlich
- Division of Psychological & Social Medicine and Developmental Neurosciences; Technische Universität Dresden, Faculty of MedicineUniversity Hospital C.G. CarusDresdenGermany
| | - Dennis van't Ent
- Department of Biological PsychologyVU University AmsterdamAmsterdamThe Netherlands
| | - Simon E Fisher
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenThe Netherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenThe Netherlands
| | - Jean‐Paul Fouche
- Department of Psychiatry and Neuroscience InstituteUniversity of Cape TownCape TownWestern CapeSouth Africa
| | - Barbara Franke
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenThe Netherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenThe Netherlands
- Department of PsychiatryRadboud University Medical CenterNijmegenThe Netherlands
| | - Paola Fuentes‐Claramonte
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
| | - Eco JC de Geus
- Department of Biological PsychologyVU University AmsterdamAmsterdamThe Netherlands
| | | | - David C Glahn
- Tommy Fuss Center for Neuropsychiatric Disease Research, Department of PsychiatryBoston Children's Hospital and Harvard Medical SchoolBostonMassachusettsUSA
- Olin Center for Neuropsychiatric Research, Institute of LivingHartford HospitalHartfordConnecticutUSA
| | - Ian H Gotlib
- Department of PsychologyStanford UniversityStanfordCaliforniaUSA
| | - Hans J Grabe
- Department of Psychiatry and PsychotherapyUniversity Medicine GreifswaldGreifswaldGermany
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg University HospitalHeidelbergGermany
| | - Patricia Gruner
- Department of PsychiatryYale UniversityNew HavenConnecticutUSA
| | - Raquel E Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Lifespan Brain InstituteChildren's Hospital of PhiladelphiaPhiladelphiaPennsylvaniaUSA
| | - Ruben C Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Tiril P Gurholt
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
| | - Lieuwe de Haan
- Department of Early PsychosisAmsterdam UMCAmsterdamThe Netherlands
| | - Beathe Haatveit
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
| | - Ben J Harrison
- Melbourne Neuropsychiatry Centre, Department of PsychiatryThe University of Melbourne & Melbourne HealthMelbourneAustralia
| | - Catharina A Hartman
- Interdisciplinary Center Psychopathology and Emotion regulationUniversity of Groningen, University Medical Center GroningenGroningenThe Netherlands
| | - Sean N Hatton
- Brain and Mind CentreUniversity of SydneySydneyNew South WalesAustralia
- Department of NeurosciencesUniversity of California San DiegoLa JollaCaliforniaUSA
| | - Dirk J Heslenfeld
- Departments of Experimental and Clinical PsychologyVrije Universiteit AmsterdamAmsterdamThe Netherlands
| | - Odile A van den Heuvel
- Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMCVrije UniversiteitAmsterdamThe Netherlands
- Department of Anatomy & Neurosciences, Amsterdam NeuroscienceAmsterdam UMC, Vrije Universiteit AmsterdamAmsterdamThe Netherlands
| | - Ian B Hickie
- Brain and Mind CentreUniversity of SydneySydneyNew South WalesAustralia
| | - Pieter J Hoekstra
- Department of PsychiatryUniversity of Groningen, University Medical Center GroningenGroningenThe Netherlands
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthUniversity of Heidelberg, Medical Faculty MannheimMannheimGermany
| | - Avram J Holmes
- Department of PsychiatryYale UniversityNew HavenConnecticutUSA
- Department of PsychologyYale UniversityNew HavenConnecticutUSA
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
| | - Martine Hoogman
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenThe Netherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenThe Netherlands
| | - Norbert Hosten
- Institute of Diagnostic Radiology and NeuroradiologyUniversity Medicine GreifswaldGreifswaldGermany
| | - Fleur M Howells
- Neuroscience InstituteUniversity of Cape TownCape TownWestern CapeSouth Africa
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownWestern CapeSouth Africa
| | - Hilleke E Hulshoff Pol
- Department of Psychiatry, University Medical Center Utrecht Brain CenterUtrecht UniversityUtrechtThe Netherlands
| | - Chaim Huyser
- De Bascule, Academic center child and adolescent psychiatryDuivendrechtThe Netherlands
- Amsterdam UMC Department of Child and Adolescent PsychiatryAmsterdamThe Netherlands
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Anthony C James
- Department of PsychiatryWarneford HospitalOxfordUK
- Highfield UnitWarneford HospitalOxfordUK
| | - Jiyang Jiang
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
| | - Erik G Jönsson
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care ServicesStockholm County CouncilStockholmSweden
| | - John A Joska
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownWestern CapeSouth Africa
| | - Andrew J Kalnin
- Department of RadiologyThe Ohio State University College of MedicineColumbusOhioUSA
| | | | - Marieke Klein
- Department of Psychiatry, University Medical Center Utrecht Brain CenterUtrecht UniversityUtrechtThe Netherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenThe Netherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenThe Netherlands
| | - Laura Koenders
- Department of Early PsychosisAmsterdam UMCAmsterdamThe Netherlands
| | - Knut K Kolskår
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
- Department of PsychologyUniversity of OsloOsloNorway
- Sunnaas Rehabilitation Hospital HTNesoddenNorway
| | - Bernd Krämer
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg University HospitalHeidelbergGermany
| | - Jonna Kuntsi
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Jim Lagopoulos
- Sunshine Coast Mind and Neuroscience Thompson InstituteBirtinyaQueenslandAustralia
- University of the Sunshine CoastSunshine CoastQueenslandAustralia
| | - Luisa Lazaro
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Department of Child and Adolescent Psychiatry and PsychologyHospital ClínicBarcelonaSpain
- August Pi i Sunyer Biomedical Research Institut (IDIBAPS)BarcelonaSpain
- Department of MedicineUniversity of BarcelonaBarcelonaSpain
| | - Irina S Lebedeva
- Laboratory of Neuroimaging and Multimodal AnalysisMental Health Research CenterMoscowRussia
| | - Phil H Lee
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
- Department of PsychiatryHarvard Medical SchoolBostonMassachusettsUSA
| | - Christine Lochner
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of PsychiatryStellenbosch UniversityCape TownWestern CapeSouth Africa
| | | | - Sophie Maingault
- Institut des maladies neurodégénérativesUniversité de BordeauxBordeauxFrance
| | - Nicholas G Martin
- Genetic EpidemiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| | - Ignacio Martínez‐Zalacaín
- Department of Psychiatry, Bellvitge University HospitalBellvitge Biomedical Research Institute‐IDIBELLBarcelonaSpain
- Department of Clinical SciencesUniversity of BarcelonaBarcelonaSpain
| | - David Mataix‐Cols
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care ServicesStockholm County CouncilStockholmSweden
| | - Bernard Mazoyer
- University of BordeauxBordeauxFrance
- Bordeaux University HospitalBordeauxFrance
| | - Brenna C McDonald
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Colm McDonald
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health SciencesNational University of Ireland GalwayGalwayIreland
| | | | - Katie L McMahon
- Herston Imaging Research Facility and School of Clinical SciencesQueensland University of Technology (QUT)BrisbaneQueenslandAustralia
- Faculty of Health, Institute of Health and Biomedical InnovationQueensland University of Technology (QUT)BrisbaneQueenslandAustralia
| | - Genevieve McPhilemy
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health SciencesNational University of Ireland GalwayGalwayIreland
| | - Dennis van der Meer
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
- School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life SciencesMaastricht UniversityMaastrichtThe Netherlands
| | - José M Menchón
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Department of Psychiatry, Bellvitge University HospitalBellvitge Biomedical Research Institute‐IDIBELLBarcelonaSpain
- Department of Clinical SciencesUniversity of BarcelonaBarcelonaSpain
| | - Jilly Naaijen
- Department of Cognitive NeuroscienceRadboud University Medical CentreNijmegenThe Netherlands
| | - Lars Nyberg
- Department of Radiation SciencesUmeå UniversityUmeåSweden
- Department of Integrative Medical BiologyUmeå UniversityUmeåSweden
| | - Jaap Oosterlaan
- Emma Children's Hospital, Amsterdam UMC University of Amsterdam and Vrije Universiteit AmsterdamEmma Neuroscience Group, Department of Pediatrics, Amsterdam Reproduction & DevelopmentAmsterdamThe Netherlands
- Clinical Neuropsychology SectionVrije Universiteit AmsterdamAmsterdamThe Netherlands
| | - Yannis Paloyelis
- Department of Neuroimaging, Institute of Psychiatry, Psychology and NeuroscienceKing's College LondonLondonUK
| | - Paul Pauli
- Department of PsychologyUniversity of WürzburgWürzburgGermany
- Centre of Mental Health, Medical FacultyUniversity of WürzburgWürzburgGermany
| | - Giulio Pergola
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
- Lieber Institute for Brain DevelopmentJohns Hopkins Medical CampusBaltimoreMary LandUSA
| | - Edith Pomarol‐Clotet
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
| | - Maria J Portella
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Department of PsychiatryInstitut d'Investigació Biomèdica Sant PauBarcelonaSpain
| | - Joaquim Radua
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care ServicesStockholm County CouncilStockholmSweden
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)BarcelonaSpain
- Early Psychosis: Interventions and Clinical‐detection (EPIC) lab, Department of Psychosis StudiesInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUK
| | - Andreas Reif
- Department of Psychiatry, Psychosomatic Medicine and PsychotherapyUniversity Hospital FrankfurtFrankfur am MaintGermany
| | - Geneviève Richard
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
| | - Joshua L Roffman
- Department of PsychiatryMassachusetts General Hospital and Harvard Medical SchoolCharlestownMassachusettsUSA
| | - Pedro GP Rosa
- Laboratory of Psychiatric Neuroimaging (LIM‐21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Matthew D Sacchet
- Center for Depression, Anxiety, and Stress ResearchMcLean Hospital, Harvard Medical SchoolBelmontMassachusettsUSA
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
- Neuropsychiatric InstituteThe Prince of Wales HospitalRandwickNew South WalesAustralia
| | - Raymond Salvador
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
| | - Salvador Sarró
- FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
| | | | - Andrew J Saykin
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
- Indiana Alzheimer Disease CenterIndianapolisIndianaUSA
| | - Mauricio H Serpa
- Laboratory of Psychiatric Neuroimaging (LIM‐21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Kang Sim
- West Region, Institute of Mental HealthSingaporeSingapore
- Yong Loo Lin School of MedicineNational University of SingaporeSingapore
| | - Andrew Simmons
- Department of Neuroimaging, Institute of PsychiatryPsychology and Neurology, King's College LondonLondonUK
| | - Jordan W Smoller
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic MedicineMassachusetts General HospitalBostonMassachusettsUSA
| | - Iris E Sommer
- Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit GroningenUniversity Medical Center GroningenGroningenThe Netherlands
| | - Carles Soriano‐Mas
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)MadridSpain
- Department of Psychiatry, Bellvitge University HospitalBellvitge Biomedical Research Institute‐IDIBELLBarcelonaSpain
- Department of Psychobiology and Methodology in Health SciencesUniversitat Autònoma de BarcelonaBarcelonaSpain
| | - Dan J Stein
- SAMRC Unit on Risk & Resilience in Mental Disorders, Dept of Psychiatry & Neuroscience InstituteUniversity of Cape TownCape TownWestern CapeSouth Africa
| | - Lachlan T Strike
- Queensland Brain InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Philip R Szeszko
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Mental Illness Research, Education and Clinical Center (MIRECC)James J. Peters VA Medical CenterNew YorkNew YorkUSA
| | - Henk S Temmingh
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownWestern CapeSouth Africa
| | - Sophia I Thomopoulos
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Alexander S Tomyshev
- Laboratory of Neuroimaging and Multimodal AnalysisMental Health Research CenterMoscowRussia
| | - Julian N Trollor
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
| | - Anne Uhlmann
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownWestern CapeSouth Africa
- Department of Child and Adolescent Psychiatry and PsychotherapyFaculty of Medicine Carl Gustav Carus of TU DresdenDresdenGermany
| | - Ilya M Veer
- Department of Psychiatry and Psychotherapy CCM, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität BerlinHumboldt‐Universität zu Berlin, and Berlin Institute of HealthBerlinGermany
| | - Dick J Veltman
- Department of Psychiatry & Amsterdam NeuroscienceAmsterdam UMC, location VUMCAmsterdamThe Netherlands
| | - Aristotle Voineskos
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of PsychiatryUniversity of TorontoTorontoCanada
| | - Henry Völzke
- Institute for Community MedicineUniversity Medicine GreifswaldGreifswaldGermany
- DZHK (German Centre for Cardiovascular Research), partner site GreifswaldGreifswaldGermany
- DZD (German Center for Diabetes Research), partner site GreifswaldGreifswaldGermany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy CCM, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität BerlinHumboldt‐Universität zu Berlin, and Berlin Institute of HealthBerlinGermany
| | - Lei Wang
- Department of Psychiatry and Behavioral SciencesNorthwestern University Feinberg School of MedicineChicagoIllinoisUSA
| | - Yang Wang
- Department of RadiologyMedical College of WisconsinMilwaukeeWisconsinUSA
| | - Bernd Weber
- Institute for Experimental Epileptology and Cognition ResearchUniversity Hospital BonnBonnGermany
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesSydneyNew South WalesAustralia
| | - John D West
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Lars T Westlye
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and AddictionOslo University HospitalOsloNorway
- Department of PsychologyUniversity of OsloOsloNorway
| | - Heather C Whalley
- Division of PsychiatryUniversity of EdinburghEdinburghUK
- Division of PsychiatryRoyal Edinburgh HospitalEdinburghUK
| | | | - Katharina Wittfeld
- Department of Psychiatry and PsychotherapyUniversity Medicine GreifswaldGreifswaldGermany
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Daniel H Wolf
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Margaret J Wright
- Queensland Brain InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
- Centre for Advanced ImagingUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Yuliya N Yoncheva
- Department of Child and Adolescent Psychiatry, NYU Child Study CenterHassenfeld Children's Hospital at NYU LangoneNew YorkNew YorkUSA
| | - Marcus V Zanetti
- Laboratory of Psychiatric Neuroimaging (LIM‐21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
- Instituto de Ensino e PesquisaHospital Sírio‐LibanêsSão PauloBrazil
| | - Georg C Ziegler
- Division of Molecular Psychiatry, Center of Mental HealthUniversity of WürzburgWürzburgGermany
| | - Greig I de Zubicaray
- Faculty of Health, Institute of Health and Biomedical InnovationQueensland University of Technology (QUT)BrisbaneQueenslandAustralia
| | - Paul M Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Eveline A Crone
- Institute of PsychologyLeiden UniversityLeidenThe Netherlands
- Leiden Institute for Brain and CognitionLeidenThe Netherlands
- Department of Psychology, Education and Child Studies (DPECS), Erasmus School of Social and Behavioral SciencesErasmus University RotterdamThe Netherlands
| | - Sophia Frangou
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA
- Centre for Brain HealthUniversity of British ColumbiaVancouverBritish ColumbiaCanada
| | - Christian K Tamnes
- Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical MedicineUniversity of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- PROMENTA Research Center, Department of PsychologyUniversity of OsloOsloNorway
| |
Collapse
|
28
|
Wells LF, Risacher SL, McDonald BC, Farlow MR, Brosch J, Gao S, Apostolova LG, Saykin AJ. Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments. J Alzheimers Dis 2022; 87:761-769. [PMID: 35367962 PMCID: PMC9169561 DOI: 10.3233/jad-215388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Self and informant (proxy or study partner) reports of everyday cognitive functioning have been shown to be associated with incipient neurodegenerative disease. The 20-item Cognitive Change Index (CCI) and the 39-item Measurement of Everyday Cognition (ECog) were each developed to characterize early subjective changes in cognitive function. OBJECTIVE We examined the relationship between CCI and ECog self and informant-based evaluations to determine content overlap and provide a co-calibration for converting between these widely used instruments. METHODS 950 participants (57.1% female, mean age = 71.2 years) from ADNI and the Indiana ADRC with self-based evaluations and 279 participants (60.9% female, mean age = 71.8 years) with informant-based evaluations (Indiana ADRC) were included. Analyzed variables for the CCI and ECog included domain mean scores, memory domain total scores, and total scores for all items. Spearman correlations, regression analyses, and frequency distributions were used to assess the relationship between CCI and ECog. Sex, age, years of education, race/ethnicity, APOE ɛ4 carrier status, and baseline diagnosis were also analyzed as potentially relevant covariates. RESULTS CCI and ECog total scores were highly correlated for the self (r = 0.795, p < 0.001) and informant-based (r = 0.840, p < 0.001) versions, as expected. Frequency distributions of self and informant total scores were generated and plotted separately. Quadratic regressions for self (r2 = 0.626) and informant (r2 = 0.741) scores were used to create a translation table between the CCI and ECog total scores. CONCLUSION Self and informant total scores can be harmonized and translated between the CCI and ECog to facilitate cross-study and longitudinal assessment of perceived cognitive change, an important patient-reported outcome.
Collapse
Affiliation(s)
| | - Shannon L. Risacher
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Brenna C. McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Martin R. Farlow
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Jared Brosch
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sujuan Gao
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Liana G. Apostolova
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Andrew J. Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
- Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
| |
Collapse
|
29
|
Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes‐Eizagirre A, Alnæs D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur‐Streubel R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Buckner RL, Calhoun V, Canales‐Rodríguez EJ, Cannon DM, Caseras X, Castellanos FX, Cervenka S, Chaim‐Avancini TM, Ching CRK, Chubar V, Clark VP, Conrod P, Conzelmann A, Crespo‐Facorro B, Crivello F, Crone EA, Dale AM, Dannlowski U, Davey C, de Geus EJC, de Haan L, de Zubicaray GI, den Braber A, Dickie EW, Di Giorgio A, Doan NT, Dørum ES, Ehrlich S, Erk S, Espeseth T, Fatouros‐Bergman H, Fisher SE, Fouche J, Franke B, Frodl T, Fuentes‐Claramonte P, Glahn DC, Gotlib IH, Grabe H, Grimm O, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Gur RE, Gur RC, Hahn T, Harrison BJ, Hartman CA, Hatton SN, Heinz A, Heslenfeld DJ, Hibar DP, Hickie IB, Ho B, Hoekstra PJ, Hohmann S, Holmes AJ, Hoogman M, Hosten N, Howells FM, Hulshoff Pol HE, Huyser C, Jahanshad N, James A, Jernigan TL, Jiang J, Jönsson EG, Joska JA, Kahn R, Kalnin A, Kanai R, Klein M, Klyushnik TP, Koenders L, Koops S, Krämer B, Kuntsi J, Lagopoulos J, Lázaro L, Lebedeva I, Lee WH, Lesch K, Lochner C, Machielsen MWJ, Maingault S, Martin NG, Martínez‐Zalacaín I, Mataix‐Cols D, Mazoyer B, McDonald C, McDonald BC, McIntosh AM, McMahon KL, McPhilemy G, Meinert S, Menchón JM, Medland SE, Meyer‐Lindenberg A, Naaijen J, Najt P, Nakao T, Nordvik JE, Nyberg L, Oosterlaan J, de la Foz VO, Paloyelis Y, Pauli P, Pergola G, Pomarol‐Clotet E, Portella MJ, Potkin SG, Radua J, Reif A, Rinker DA, Roffman JL, Rosa PGP, Sacchet MD, Sachdev PS, Salvador R, Sánchez‐Juan P, Sarró S, Satterthwaite TD, Saykin AJ, Serpa MH, Schmaal L, Schnell K, Schumann G, Sim K, Smoller JW, Sommer I, Soriano‐Mas C, Stein DJ, Strike LT, Swagerman SC, Tamnes CK, Temmingh HS, Thomopoulos SI, Tomyshev AS, Tordesillas‐Gutiérrez D, Trollor JN, Turner JA, Uhlmann A, van den Heuvel OA, van den Meer D, van der Wee NJA, van Haren NEM, van 't Ent D, van Erp TGM, Veer IM, Veltman DJ, Voineskos A, Völzke H, Walter H, Walton E, Wang L, Wang Y, Wassink TH, Weber B, Wen W, West JD, Westlye LT, Whalley H, Wierenga LM, Wittfeld K, Wolf DH, Worker A, Wright MJ, Yang K, Yoncheva Y, Zanetti MV, Ziegler GC, Thompson PM, Dima D. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. Hum Brain Mapp 2022; 43:431-451. [PMID: 33595143 PMCID: PMC8675431 DOI: 10.1002/hbm.25364] [Citation(s) in RCA: 97] [Impact Index Per Article: 48.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 01/02/2021] [Accepted: 01/21/2021] [Indexed: 12/25/2022] Open
Abstract
Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes.
Collapse
Affiliation(s)
- Sophia Frangou
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew York CityNew YorkUSA
- Department of Psychiatry, Djavad Mowafaghian Centre for Brain HealthUniversity of British ColumbiaVancouverCanada
| | | | - Steven C. R. Williams
- Department of NeuroimagingInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
| | - Efstathios Papachristou
- Psychology and Human DevelopmentInstitute of Education, University College LondonLondonUnited Kingdom
| | - Gaelle E. Doucet
- Institute for Human NeuroscienceBoys Town National Research HospitalOmahaNebraskaUSA
| | - Ingrid Agartz
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetSolnaSweden
| | - Moji Aghajani
- Department of PsychiatryAmsterdam University Medical Centre, Vrije UniversiteitAmsterdamNetherlands
- Section Forensic Family & Youth CareInstitute of Education & Child StudiesLeiden UniversityNetherlands
| | - Theophilus N. Akudjedu
- Institute of Medical Imaging and Visualisation, Department of Medical Science and Public Health, Faculty of Health and Social SciencesBournemouth UniversityPooleUnited Kingdom
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandGalwayIreland
| | - Anton Albajes‐Eizagirre
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - Dag Alnæs
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
- Division of Mental Health and AddictionInstitute of Clinical Medicine, University of OsloOsloNorway
| | | | - Micael Andersson
- Department of Integrative Medical BiologyUmeå UniversityUmeåSweden
| | - Nancy C. Andreasen
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Ole A. Andreassen
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
| | - Philip Asherson
- Social, Genetic and Developmental Psychiatry CentreInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityHeidelbergGermany
| | - Nuria Bargallo
- Imaging Diagnostic CentreHospital Clinic, Barcelona University ClinicBarcelonaSpain
- August Pi i Sunyer Biomedical Research Institut (IDIBAPS)BarcelonaSpain
| | - Sarah Baumeister
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityHeidelbergGermany
| | - Ramona Baur‐Streubel
- Department of Psychology, Biological Psychology, Clinical Psychology and PsychotherapyUniversity of WürzburgWürzburgGermany
| | - Alessandro Bertolino
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Aurora Bonvino
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Dorret I. Boomsma
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Stefan Borgwardt
- Department of Psychiatry & PsychotherapyUniversity of LübeckLübeckGermany
| | - Josiane Bourque
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Daniel Brandeis
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityHeidelbergGermany
| | - Alan Breier
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesKensingtonNew South WalesAustralia
| | - Rachel M. Brouwer
- Rudolf Magnus Institute of NeuroscienceUniversity Medical Center UtrechtUtrechtNetherlands
| | - Jan K. Buitelaar
- Donders Center of Medical NeurosciencesRadboud UniversityNijmegenNetherlands
- Donders Centre for Cognitive NeuroimagingRadboud UniversityNijmegenNetherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
| | - Geraldo F. Busatto
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Randy L. Buckner
- Department of Psychology, Center for Brain ScienceHarvard UniversityCambridgeMassachusettsUSA
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
| | - Vincent Calhoun
- Tri‐Institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of TechnologyEmory University, USA Neurology, Radiology, Psychiatry and Biomedical Engineering, Emory UniversityAtlantaGeorgiaUSA
| | - Erick J. Canales‐Rodríguez
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - Dara M. Cannon
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandGalwayIreland
| | - Xavier Caseras
- MRC Centre for Neuropsychiatric Genetics and GenomicsCardiff UniversityCardiffUnited Kingdom
| | | | - Simon Cervenka
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetSolnaSweden
- Stockholm Health Care ServicesStockholmSweden
| | - Tiffany M. Chaim‐Avancini
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Christopher R. K. Ching
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaMarina del ReyCaliforniaUSA
| | - Victoria Chubar
- Mind‐Body Research Group, Department of NeuroscienceKU LeuvenLeuvenBelgium
| | - Vincent P. Clark
- Department of PsychologyUniversity of New MexicoAlbuquerqueNew MexicoUSA
- Mind Research NetworkAlbuquerqueNew MexicoUSA
| | - Patricia Conrod
- Department of PsychiatryUniversité de MontréalMontrealCanada
| | - Annette Conzelmann
- Department of Child and Adolescent Psychiatry, Psychosomatics and PsychotherapyUniversity of TübingenTübingenGermany
| | - Benedicto Crespo‐Facorro
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- HU Virgen del Rocio, IBiSUniversity of SevillaSevillaSpain
| | - Fabrice Crivello
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxBordeauxFrance
| | - Eveline A. Crone
- Erasmus School of Social and Behavioural SciencesErasmus University RotterdamRotterdamNetherlands
- Faculteit der Sociale Wetenschappen, Instituut PsychologieUniversiteit LeidenLeidenNetherlands
| | - Anders M. Dale
- Center for Multimodal Imaging and Genetics, Department of NeuroscienceUniversity of California‐San DiegoSan DiegoCaliforniaUSA
- Department of RadiologyUniversity of California‐San DiegoSan DiegoCaliforniaUSA
| | - Udo Dannlowski
- Department of Psychiatry and PsychotherapyUniversity of MünsterGermany
| | | | - Eco J. C. de Geus
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Lieuwe de Haan
- Academisch Medisch CentrumUniversiteit van AmsterdamAmsterdamNetherlands
| | - Greig I. de Zubicaray
- Faculty of Health, Institute of Health and Biomedical InnovationQueensland University of TechnologyQueenslandAustralia
| | - Anouk den Braber
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Erin W. Dickie
- Kimel Family Translational Imaging Genetics Laboratory, Campbell Family Mental Health Research InstituteCAMHCampbellCanada
- Department of PsychiatryUniversity of TorontoTorontoCanada
| | - Annabella Di Giorgio
- Biological Psychiatry LabFondazione IRCCS Casa Sollievo della SofferenzaSan Giovanni Rotondo (FG)Italy
| | - Nhat Trung Doan
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
| | - Erlend S. Dørum
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
- Department of PsychologyUniversity of OsloOsloNorway
- Sunnaas Rehabilitation Hospital HTNesoddenNorway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental NeurosciencesTechnische Universität DresdenDresdenGermany
- Faculty of MedicineUniversitätsklinikum Carl Gustav Carus an der TU DresdenDresdenGermany
| | - Susanne Erk
- Division of Mind and Brain Research, Department of Psychiatry and PsychotherapyCharité‐Universitätsmedizin BerlinBerlinGermany
| | - Thomas Espeseth
- Biological Psychiatry LabFondazione IRCCS Casa Sollievo della SofferenzaSan Giovanni Rotondo (FG)Italy
- Bjørknes CollegeOsloNorway
| | - Helena Fatouros‐Bergman
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetSolnaSweden
- Stockholm Health Care ServicesStockholmSweden
| | - Simon E. Fisher
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Language and Genetics DepartmentMax Planck Institute for PsycholinguisticsNijmegenNetherlands
| | - Jean‐Paul Fouche
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
| | - Barbara Franke
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenNetherlands
- Department of PsychiatryRadboud University Medical CenterNijmegenNetherlands
| | - Thomas Frodl
- Department of Psychiatry and PsychotherapyOtto von Guericke University MagdeburgMagdeburgGermany
| | - Paola Fuentes‐Claramonte
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - David C. Glahn
- Department of PsychiatryTommy Fuss Center for Neuropsychiatric Disease Research Boston Children's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Ian H. Gotlib
- Department of PsychologyStanford UniversityStanfordCaliforniaUSA
| | - Hans‐Jörgen Grabe
- Department of Psychiatry and PsychotherapyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Oliver Grimm
- Department for Psychiatry, Psychosomatics and PsychotherapyUniversitätsklinikum Frankfurt, Goethe UniversitatFrankfurtGermany
| | - Nynke A. Groenewold
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
- Neuroscience InstituteUniversity of Cape TownCape TownSouth Africa
| | | | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg UniversityHeidelbergGermany
| | - Patricia Gruner
- Department of PsychiatryYale UniversityNew HavenConnecticutUSA
- Learning Based Recovery CenterVA Connecticut Health SystemWest HavenConnecticutUSA
| | - Rachel E. Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Lifespan Brain Institute, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Children's Hospital of PhiladelphiaUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Ruben C. Gur
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Lifespan Brain Institute, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
- Children's Hospital of PhiladelphiaUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Tim Hahn
- Department of Psychiatry and PsychotherapyUniversity of MünsterGermany
| | - Ben J. Harrison
- Melbourne Neuropsychiatry CenterUniversity of MelbourneMelbourneAustralia
| | - Catharine A. Hartman
- Interdisciplinary Center Psychopathology and Emotion regulationUniversity Medical Center Groningen, University of GroningenGroningenNetherlands
| | - Sean N. Hatton
- Brain and Mind CentreUniversity of SydneySydneyAustralia
| | - Andreas Heinz
- Division of Mind and Brain Research, Department of Psychiatry and PsychotherapyCharité‐Universitätsmedizin BerlinBerlinGermany
| | - Dirk J. Heslenfeld
- Departments of Experimental and Clinical PsychologyVrije Universiteit AmsterdamAmsterdamNetherlands
| | - Derrek P. Hibar
- Personalized Healthcare, Genentech, Inc.South San FranciscoCaliforniaUSA
| | - Ian B. Hickie
- Brain and Mind CentreUniversity of SydneySydneyAustralia
| | - Beng‐Choon Ho
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Pieter J. Hoekstra
- Department of PsychiatryUniversity Medical Center Groningen, University of GroningenGroningenNetherlands
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthHeidelberg UniversityHeidelbergGermany
| | - Avram J. Holmes
- Department of PsychologyYale UniversityNew HavenConnecticutUSA
| | - Martine Hoogman
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenNetherlands
| | - Norbert Hosten
- Norbert Institute of Diagnostic Radiology and NeuroradiologyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
| | - Fleur M. Howells
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
- Neuroscience InstituteUniversity of Cape TownCape TownSouth Africa
| | | | - Chaim Huyser
- De Bascule, Academic Centre for Children and Adolescent PsychiatryAmsterdamNetherlands
| | - Neda Jahanshad
- Mind‐Body Research Group, Department of NeuroscienceKU LeuvenLeuvenBelgium
| | - Anthony James
- Department of PsychiatryOxford UniversityOxfordUnited Kingdom
| | - Terry L. Jernigan
- Center for Human Development, Departments of Cognitive Science, Psychiatry, and RadiologyUniversity of CaliforniaSan DiegoCaliforniaUSA
| | - Jiyang Jiang
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesKensingtonNew South WalesAustralia
| | - Erik G. Jönsson
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
| | - John A. Joska
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
| | - Rene Kahn
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew York CityNew YorkUSA
| | - Andrew Kalnin
- Department of RadiologyOhio State University College of MedicineColumbusOhioUSA
| | - Ryota Kanai
- Department of NeuroinformaticsAraya, Inc.TokyoJapan
| | - Marieke Klein
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
- Department of Human GeneticsRadboud University Medical CenterNijmegenNetherlands
- Department of PsychiatryUniversity of California San DiegoSan DiegoCaliforniaUSA
| | | | - Laura Koenders
- Academisch Medisch CentrumUniversiteit van AmsterdamAmsterdamNetherlands
| | - Sanne Koops
- Rudolf Magnus Institute of NeuroscienceUniversity Medical Center UtrechtUtrechtNetherlands
| | - Bernd Krämer
- Section for Experimental Psychopathology and Neuroimaging, Department of General PsychiatryHeidelberg UniversityHeidelbergGermany
| | - Jonna Kuntsi
- Social, Genetic and Developmental Psychiatry CentreInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
| | - Jim Lagopoulos
- Sunshine Coast Mind and NeuroscienceThompson Institute, University of the Sunshine CoastQueenslandAustralia
| | - Luisa Lázaro
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of Child and Adolescent Psychiatry and PsychologyHospital Clinic, University of BarcelonaBarcelonaSpain
| | - Irina Lebedeva
- Mental Health Research CenterRussian Academy of Medical SciencesMoscowRussia
| | - Won Hee Lee
- Department of PsychiatryIcahn School of Medicine at Mount SinaiNew York CityNew YorkUSA
| | - Klaus‐Peter Lesch
- Department of Psychiatry, Psychosomatics and PsychotherapyJulius‐Maximilians Universität WürzburgWürzburgGermany
| | - Christine Lochner
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of PsychiatryStellenbosch UniversityStellenboschSouth Africa
| | | | - Sophie Maingault
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxBordeauxFrance
| | - Nicholas G. Martin
- Queensland Institute of Medical ResearchBerghofer Medical Research InstituteQueenslandAustralia
| | - Ignacio Martínez‐Zalacaín
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - David Mataix‐Cols
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetSolnaSweden
- Stockholm Health Care ServicesStockholmSweden
| | - Bernard Mazoyer
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR5293Université de BordeauxBordeauxFrance
| | - Colm McDonald
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandGalwayIreland
| | - Brenna C. McDonald
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | | | - Katie L. McMahon
- School of Clinical Sciences, Institute of Health and Biomedical InnovationQueensland University of TechnologyQueenslandAustralia
| | - Genevieve McPhilemy
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandGalwayIreland
| | - Susanne Meinert
- Department of Psychiatry and PsychotherapyUniversity of MünsterGermany
| | - José M. Menchón
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - Sarah E. Medland
- Queensland Institute of Medical ResearchBerghofer Medical Research InstituteQueenslandAustralia
| | - Andreas Meyer‐Lindenberg
- Department of Psychiatry and PsychotherapyCentral Institute of Mental Health, Heidelberg UniversityHeidelbergGermany
| | - Jilly Naaijen
- Donders Centre for Cognitive NeuroimagingRadboud UniversityNijmegenNetherlands
- Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenNetherlands
| | - Pablo Najt
- Clinical Neuroimaging Laboratory, Centre for Neuroimaging and Cognitive Genomics and NCBES Galway Neuroscience CentreNational University of IrelandGalwayIreland
| | - Tomohiro Nakao
- Department of Clinical MedicineKyushu UniversityFukuokaJapan
| | | | - Lars Nyberg
- Department of Integrative Medical BiologyUmeå UniversityUmeåSweden
- Department of Radiation SciencesUmeå Center for Functional Brain Imaging, Umeå UniversityUmeåSweden
| | - Jaap Oosterlaan
- Department of Clinical NeuropsychologyAmsterdam University Medical Centre, Vrije Universiteit AmsterdamAmsterdamNetherlands
| | - Víctor Ortiz‐García de la Foz
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryUniversity Hospital “Marques de Valdecilla”, Instituto de Investigación Valdecilla (IDIVAL)SantanderSpain
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)Instituto de Salud Carlos IIIMadridSpain
| | - Yannis Paloyelis
- Department of NeuroimagingInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
| | - Paul Pauli
- Department of Psychology, Biological Psychology, Clinical Psychology and PsychotherapyUniversity of WürzburgWürzburgGermany
- Centre of Mental HealthUniversity of WürzburgWürzburgGermany
| | - Giulio Pergola
- Department of Basic Medical Science, Neuroscience and Sense OrgansUniversity of Bari Aldo MoroBariItaly
| | - Edith Pomarol‐Clotet
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
| | - Maria J. Portella
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Department of PsychiatryHospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Steven G. Potkin
- Department of PsychiatryUniversity of California at IrvineIrvineCaliforniaUSA
| | - Joaquim Radua
- Centre for Psychiatric Research, Department of Clinical NeuroscienceKarolinska InstitutetSolnaSweden
- August Pi i Sunyer Biomedical Research Institut (IDIBAPS)BarcelonaSpain
- Department of Psychosis StudiesInstitute of Psychiatry, Psychology & Neuroscience, King's College LondonLondonUnited Kingdom
| | - Andreas Reif
- Department for Psychiatry, Psychosomatics and PsychotherapyUniversitätsklinikum Frankfurt, Goethe UniversitatFrankfurtGermany
| | - Daniel A. Rinker
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
| | - Joshua L. Roffman
- Department of PsychiatryMassachusetts General HospitalBostonMassachusettsUSA
| | - Pedro G. P. Rosa
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Matthew D. Sacchet
- Center for Depression, Anxiety, and Stress ResearchMcLean Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesKensingtonNew South WalesAustralia
| | | | - Pascual Sánchez‐Juan
- Department of PsychiatryUniversity Hospital “Marques de Valdecilla”, Instituto de Investigación Valdecilla (IDIVAL)SantanderSpain
- Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)ValderrebolloSpain
| | | | | | - Andrew J. Saykin
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | - Mauricio H. Serpa
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
| | - Lianne Schmaal
- OrygenThe National Centre of Excellence in Youth Mental HealthMelbourneAustralia
- Centre for Youth Mental HealthThe University of MelbourneMelbourneAustralia
| | - Knut Schnell
- Department of Psychiatry and PsychotherapyUniversity Medical Center GöttingenGöttingenGermany
| | - Gunter Schumann
- Social, Genetic and Developmental Psychiatry CentreInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
- Centre for Population Neuroscience and Precision MedicineInstitute of Psychiatry, Psychology & Neuroscience, King's College LondonLondonUnited Kingdom
| | - Kang Sim
- Department of General PsychiatryInstitute of Mental HealthSingaporeSingapore
| | - Jordan W. Smoller
- Center for Genomic MedicineMassachusetts General HospitalBostonMassachusettsUSA
| | - Iris Sommer
- Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit GroningenUniversity Medical Center GroningenGroningenNetherlands
| | - Carles Soriano‐Mas
- Mental Health Research Networking Center (CIBERSAM)MadridSpain
- Department of PsychiatryBellvitge University Hospital‐IDIBELL, University of BarcelonaBarcelonaSpain
| | - Dan J. Stein
- SA MRC Unit on Risk and Resilience in Mental Disorders, Department of PsychiatryStellenbosch UniversityStellenboschSouth Africa
| | - Lachlan T. Strike
- Queensland Brain InstituteUniversity of QueenslandQueenslandAustralia
| | | | - Christian K. Tamnes
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
- Department of Psychiatric ResearchDiakonhjemmet HospitalOsloNorway
- PROMENTA Research Center, Department of PsychologyUniversity of OsloOsloNorway
| | - Henk S. Temmingh
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
| | - Sophia I. Thomopoulos
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaMarina del ReyCaliforniaUSA
| | | | - Diana Tordesillas‐Gutiérrez
- FIDMAG Germanes HospitalàriesBarcelonaSpain
- Neuroimaging Unit, Technological FacilitiesValdecilla Biomedical Research Institute IDIVALCantabriaSpain
| | - Julian N. Trollor
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesKensingtonNew South WalesAustralia
| | - Jessica A. Turner
- College of Arts and SciencesGeorgia State UniversityAtlantaGeorgiaUSA
| | - Anne Uhlmann
- Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
| | - Odile A. van den Heuvel
- Department of PsychiatryAmsterdam University Medical Centre, Vrije UniversiteitAmsterdamNetherlands
| | - Dennis van den Meer
- Norwegian Centre for Mental Disorders Research (NORMENT)Institute of Clinical Medicine, University of OsloOsloNorway
- Division of Mental Health and AddictionInstitute of Clinical Medicine, University of OsloOsloNorway
- School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life SciencesMaastricht UniversityMaastrichtNetherlands
| | - Nic J. A. van der Wee
- Department of PsychiatryLeiden University Medical CenterLeidenNetherlands
- Leiden Institute for Brain and CognitionLeiden University Medical CenterLeidenNetherlands
| | - Neeltje E. M. van Haren
- Department of Child and Adolescent Psychiatry/PsychologyErasmus University Medical Center, Sophia Children's HospitalRotterdamThe Netherlands
| | - Dennis van 't Ent
- Department of Biological PsychologyVrije UniversiteitAmsterdamNetherlands
| | - Theo G. M. van Erp
- Department of PsychiatryUniversity of California at IrvineIrvineCaliforniaUSA
- Center for the Neurobiology of Learning and MemoryUniversity of California IrvineIrvineCaliforniaUSA
- Institute of Community MedicineUniversity Medicine, Greifswald, University of GreifswaldGreifswaldGermany
| | - Ilya M. Veer
- Division of Mind and Brain Research, Department of Psychiatry and PsychotherapyCharité‐Universitätsmedizin BerlinBerlinGermany
| | - Dick J. Veltman
- Department of PsychiatryAmsterdam University Medical Centre, Vrije UniversiteitAmsterdamNetherlands
| | - Aristotle Voineskos
- Kimel Family Translational Imaging Genetics Laboratory, Campbell Family Mental Health Research InstituteCAMHCampbellCanada
- Department of PsychiatryUniversity of TorontoTorontoCanada
| | - Henry Völzke
- Institute of Community MedicineUniversity Medicine, Greifswald, University of GreifswaldGreifswaldGermany
- German Centre for Cardiovascular Research (DZHK), partner site GreifswaldGreifswaldGermany
- German Center for Diabetes Research (DZD), partner site GreifswaldGreifswaldGermany
| | - Henrik Walter
- Division of Mind and Brain Research, Department of Psychiatry and PsychotherapyCharité‐Universitätsmedizin BerlinBerlinGermany
| | - Esther Walton
- Department of PsychologyUniversity of BathBathUnited Kingdom
| | - Lei Wang
- Department of Psychiatry and Behavioral Sciences, Feinberg School of MedicineNorthwestern UniversityEvanstonIllinoisUSA
| | - Yang Wang
- Department of RadiologyMedical College of WisconsinMilwaukeeWisconsinUSA
| | - Thomas H. Wassink
- Department of Psychiatry, Carver College of MedicineThe University of IowaIowa CityIowaUSA
| | - Bernd Weber
- Institute for Experimental Epileptology and Cognition ResearchUniversity of BonnBonnGermany
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of PsychiatryUniversity of New South WalesKensingtonNew South WalesAustralia
| | - John D. West
- Department of Radiology and Imaging SciencesIndiana University School of MedicineIndianapolisIndianaUSA
| | | | - Heather Whalley
- Division of PsychiatryUniversity of EdinburghEdinburghUnited Kingdom
| | - Lara M. Wierenga
- Developmental and Educational Psychology Unit, Institute of PsychologyLeiden UniversityLeidenNetherlands
| | - Katharina Wittfeld
- Department of Psychiatry and PsychotherapyUniversity Medicine Greifswald, University of GreifswaldGreifswaldGermany
- German Center for Neurodegenerative Diseases (DZNE)Site Rostock/GreifswaldGreifswaldGermany
| | - Daniel H. Wolf
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Amanda Worker
- Department of Psychiatry, Djavad Mowafaghian Centre for Brain HealthUniversity of British ColumbiaVancouverCanada
| | | | - Kun Yang
- National High Magnetic Field LaboratoryFlorida State UniversityTallahasseeFloridaUSA
| | - Yulyia Yoncheva
- Department of Child and Adolescent Psychiatry, Child Study CenterNYU Langone HealthNew York CityNew YorkUSA
| | - Marcus V. Zanetti
- Laboratory of Psychiatric Neuroimaging, Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil
- Instituto de Ensino e PesquisaHospital Sírio‐LibanêsSão PauloBrazil
| | - Georg C. Ziegler
- Division of Molecular Psychiatry, Center of Mental HealthUniversity of WürzburgWürzburgGermany
| | | | - Paul M. Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of MedicineUniversity of Southern CaliforniaMarina del ReyCaliforniaUSA
| | - Danai Dima
- Department of NeuroimagingInstitute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom
- Department of Psychology, School of Arts and Social SciencesCity University of LondonLondonUnited Kingdom
| |
Collapse
|
30
|
Price LR, Deardorff R, Wu Y, McDonald BC, West JD, Risacher SL, Saykin AJ. Comparison of diffusion weighted, imaging‐derived, fractional anisotropy with a novel MRI contrast‐weighted ratio method for measuring myelin in older adults at risk for Alzheimer’s disease. Alzheimers Dement 2021. [DOI: 10.1002/alz.055560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
| | - Rachael Deardorff
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Yu‐Chien Wu
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - Brenna C. McDonald
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - John D. West
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Shannon L. Risacher
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Andrew J. Saykin
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis IN USA
| |
Collapse
|
31
|
Risacher SL, Deardorff R, West JD, Vosmeier A, Tallman EF, McDonald BC, Farlow MR, Brosch JR, Gao S, Apostolova LG, Saykin AJ. Brain activation during episodic scene encoding is associated with amyloid and tau levels in amyloid‐positive older adults. Alzheimers Dement 2021. [DOI: 10.1002/alz.056463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Shannon L. Risacher
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Rachael Deardorff
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - John D. West
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Aaron Vosmeier
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Eileen F. Tallman
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Brenna C. McDonald
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Martin R. Farlow
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Jared R. Brosch
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Sujuan Gao
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Liana G. Apostolova
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Andrew J. Saykin
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| |
Collapse
|
32
|
Swinford CG, Risacher SL, West JD, McDonald BC, Unverzagt FW, Gao S, Farlow MR, Apostolova LG, Wu Y, Brosch JR, Deardorff R, Wang S, Kamer AP, Wang DJ, Saykin AJ. Hypertension and race affect cerebral blood flow and cognition in older adults without dementia. Alzheimers Dement 2021. [DOI: 10.1002/alz.056398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - Shannon L. Risacher
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - John D. West
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Brenna C. McDonald
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University Network Science Institute Bloomington IN USA
| | - Fred W. Unverzagt
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - Sujuan Gao
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Martin R. Farlow
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis IN USA
- Department of Neurology Indiana University School of Medicine Indianapolis IN USA
| | - Liana G. Apostolova
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University Network Science Institute Bloomington IN USA
- Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis IN USA
- Department of Neurology Indiana University School of Medicine Indianapolis IN USA
| | - Yu‐Chien Wu
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - Jared R. Brosch
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Rachael Deardorff
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Sophia Wang
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
| | - Aaron P. Kamer
- Indiana University School of Medicine Indianapolis IN USA
| | | | - Andrew J. Saykin
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer's Disease Research Center Indianapolis IN USA
- Indiana University Network Science Institute Bloomington IN USA
- Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis IN USA
| |
Collapse
|
33
|
Mandelblatt JS, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, Extermann M, Graham D, Jacobsen PB, Jim H, McDonald BC, Patel SK, Root JC, Saykin AJ, Cohen HJ, Carroll JE. Response to Dekker, Stege, and Versteeg. J Natl Cancer Inst 2021; 113:1436-1437. [PMID: 33823011 PMCID: PMC8486326 DOI: 10.1093/jnci/djab060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Accepted: 03/29/2021] [Indexed: 11/12/2022] Open
Affiliation(s)
- Jeanne S Mandelblatt
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, and Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Tim Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
| | - Martine Extermann
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
| | | | - Paul B Jacobsen
- Division of Cancer Control and Population Sciences, Healthcare Delivery Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Heather Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sunita K Patel
- Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging , Indiana University School of Medicine, Indianapolis, IN, USA
| | - Harvey Jay Cohen
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA
| | - Judith E Carroll
- UCLA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and Cousins Center for Psychoneuroimmunology, Los Angeles, CA, USA
| |
Collapse
|
34
|
Rentscher KE, Zhou X, Small BJ, Cohen HJ, Dilawari AA, Patel SK, Bethea TN, Van Dyk KM, Nakamura ZM, Ahn J, Zhai W, Ahles TA, Jim HSL, McDonald BC, Saykin AJ, Root JC, Graham DMA, Carroll JE, Mandelblatt JS. Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls. Cancer 2021; 127:3671-3679. [PMID: 34161601 PMCID: PMC8419003 DOI: 10.1002/cncr.33687] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Revised: 05/17/2021] [Accepted: 05/28/2021] [Indexed: 12/31/2022]
Abstract
Background The coronavirus disease 2019 (COVID‐19) pandemic has had wide‐ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic. Methods The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at parent study enrollment and then annually, including a web‐based or telephone COVID‐19 survey, between May 27 and September 11, 2020. Mixed‐effects models were used to examine changes in loneliness (a single item on the Center for Epidemiologic Studies–Depression [CES‐D] scale) from before to during the pandemic in survivors versus controls and to test survivor‐control differences in the associations between changes in loneliness and changes in mental health, including depression (CES‐D, excluding the loneliness item), anxiety (the State‐Trait Anxiety Inventory), and perceived stress (the Perceived Stress Scale). Models were adjusted for age, race, county COVID‐19 death rates, and time between assessments. Results Loneliness increased from before to during the pandemic (0.211; P = .001), with no survivor‐control differences. Increased loneliness was associated with worsening depression (3.958; P < .001) and anxiety (3.242; P < .001) symptoms and higher stress (1.172; P < .001) during the pandemic, also with no survivor‐control differences. Conclusions Cancer survivors reported changes in loneliness and mental health similar to those reported by women without cancer. However, both groups reported increased loneliness from before to during the pandemic that was related to worsening mental health, suggesting that screening for loneliness during medical care interactions will be important for identifying all older women at risk for adverse mental health effects of the pandemic. Older breast cancer survivors and matched noncancer controls experienced similar increases in loneliness from before to during the COVID‐19 pandemic. Women who reported increased loneliness also experienced worsening depression and anxiety symptoms and higher stress during the pandemic.
Collapse
Affiliation(s)
- Kelly E Rentscher
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California.,Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California
| | - Xingtao Zhou
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
| | - Brent J Small
- School of Aging Studies, University of South Florida, Tampa, Florida
| | - Harvey J Cohen
- Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina
| | - Asma A Dilawari
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
| | - Sunita K Patel
- Outcomes Division, Population Sciences, City of Hope National Medical Center, Los Angeles, California
| | - Traci N Bethea
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
| | - Kathleen M Van Dyk
- Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California
| | - Zev M Nakamura
- Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, District of Columbia
| | - Wanting Zhai
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
| | | | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Deena M A Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey
| | - Judith E Carroll
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California.,Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California
| | - Jeanne S Mandelblatt
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
| |
Collapse
|
35
|
Chumin EJ, Risacher SL, West JD, Apostolova LG, Farlow MR, McDonald BC, Wu YC, Saykin AJ, Sporns O. Temporal stability of the ventral attention network and general cognition along the Alzheimer's disease spectrum. Neuroimage Clin 2021; 31:102726. [PMID: 34153687 PMCID: PMC8220588 DOI: 10.1016/j.nicl.2021.102726] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Revised: 05/24/2021] [Accepted: 06/09/2021] [Indexed: 02/01/2023]
Abstract
Understanding the interrelationships of clinical manifestations of Alzheimer's disease (AD) and functional connectivity (FC) as the disease progresses is necessary for use of FC as a potential neuroimaging biomarker. Degradation of resting-state networks in AD has been observed when FC is estimated over the entire scan, however, the temporal dynamics of these networks are less studied. We implemented a novel approach to investigate the modular structure of static (sFC) and time-varying (tvFC) connectivity along the AD spectrum in a two-sample Discovery/Validation design (n = 80 and 81, respectively). Cortical FC networks were estimated across 4 diagnostic groups (cognitively normal, subjective cognitive decline, mild cognitive impairment, and AD) for whole scan (sFC) and with sliding window correlation (tvFC). Modularity quality (across a range of spatial scales) did not differ in either sFC or tvFC. For tvFC, group differences in temporal stability within and between multiple resting state networks were observed; however, these differences were not consistent between samples. Correlation analyses identified a relationship between global cognition and temporal stability of the ventral attention network, which was reproduced in both samples. While the ventral attention system has been predominantly studied in task-evoked designs, the relationship between its intrinsic dynamics at-rest and general cognition along the AD spectrum highlights its relevance regarding clinical manifestation of the disease.
Collapse
Affiliation(s)
- Evgeny J. Chumin
- Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA,Indiana University Network Science Institute, Bloomington, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Corresponding author at: Psychology Building 308, 1101 E 10th St, Bloomington, IN 47405, USA.
| | - Shannon L. Risacher
- Indiana University Network Science Institute, Bloomington, IN, USA,Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Department of Neurology, IUSM, Indianapolis, IN, USA
| | - John D. West
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA
| | - Liana G. Apostolova
- Indiana University Network Science Institute, Bloomington, IN, USA,Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Martin R. Farlow
- Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Brenna C. McDonald
- Indiana University Network Science Institute, Bloomington, IN, USA,Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Yu-Chien Wu
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA
| | - Andrew J. Saykin
- Indiana University Network Science Institute, Bloomington, IN, USA,Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA,Department of Neurology, IUSM, Indianapolis, IN, USA
| | - Olaf Sporns
- Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA,Indiana University Network Science Institute, Bloomington, IN, USA,Department of Radiology and Imaging Sciences, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA,Indiana Alzheimer’s Disease Research Center, IUSM, Indianapolis, IN, USA
| |
Collapse
|
36
|
Kesler SR, Sleurs C, McDonald BC, Deprez S, van der Plas E, Nieman BJ. Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment. J Clin Oncol 2021; 39:1775-1785. [PMID: 33886371 DOI: 10.1200/jco.20.02315] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Affiliation(s)
- Shelli R Kesler
- School of Nursing, Department of Diagnostic Medicine, Dell School of Medicine, Livestrong Cancer Institutes, Austin, TX
| | - Charlotte Sleurs
- Department of Oncology, Catholic University of Leuven, Leuven, Belgium.,Leuven Cancer Institute, Leuven, Belgium
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Center for Neuroimaging, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN
| | - Sabine Deprez
- Leuven Cancer Institute, Leuven, Belgium.,Department of Imaging and Pathology, Catholic University of Leuven, Leuven, Belgium
| | - Ellen van der Plas
- Department of Psychiatry, University of Iowa Hospital and Clinics, Iowa City, Iowa
| | - Brian J Nieman
- Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.,Ontario Institute for Cancer Research, Toronto, ON, Canada.,Translational Medicine, Hospital for Sick Children, Toronto, ON, Canada
| |
Collapse
|
37
|
Van Dyk K, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, Graham D, Jacobsen PB, Jim H, McDonald BC, Nudelman Holohan K, Patel SK, Rebeck GW, Root JC, Saykin AJ, Cohen HJ, Mandelblatt JS, Carroll JE. Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. JNCI Cancer Spectr 2021; 5:pkab013. [PMID: 33748669 PMCID: PMC7962698 DOI: 10.1093/jncics/pkab013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Accepted: 01/21/2021] [Indexed: 11/14/2022] Open
Abstract
Background Cancer-related cognitive decline (CRCD) has been linked to apolipoprotein E (APOE) gene ε4 polymorphisms. APOE ε4 polymorphisms are also the strongest genetic risk for late-onset Alzheimer disease (AD), whereas ε2 polymorphisms protect against AD. However, the effects of ε2 polymorphisms on CRCD have not been evaluated. Methods We evaluated nonmetastatic breast cancer survivors (n = 427) and matched noncancer controls (n = 407) ages 60-98 years assessed presystemic therapy from August 2010 to December 2017 with annual follow-up to 24 months. Neuropsychological assessment measured attention, processing speed, executive function, and learning and memory. Linear mixed-effects models tested the effects of having an ε2 allele (vs none) on longitudinal cognitive domain z scores by treatment group (chemotherapy with or without hormonal therapy, hormonal therapy, and control) controlling for covariates; participants with ε2/ε4 genotype were excluded. Sensitivity analyses examined effects of other covariates and any ε4 positivity. Results There was an interaction with genotype for attention, processing speed, and executive functioning domain scores (Beta = 0.32, 95% confidence interval = 0.00 to 0.65); the chemotherapy group with an ε2 allele had higher scores at baseline and maintained higher scores over time compared with those without an ε2 allele, and this protective effect was not seen for other groups. There was no effect of ε2 on learning and memory domain scores. Conclusions APOE ε2 polymorphisms may protect against CRCD in older breast cancer survivors receiving chemotherapy. With replication, this information could be useful for survivorship care and informing future studies of possible links to AD and defining mechanisms of protection.
Collapse
Affiliation(s)
- Kathleen Van Dyk
- UCLA Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, and Senior Member, Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Tim Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
| | | | - Paul B Jacobsen
- Division of Cancer Control and Population Sciences, Healthcare Delivery Research Program, National Cancer Institute, Bethesda, MD, USA
| | - Heather Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Kelly Nudelman Holohan
- Department of Medical and Molecular Genetics, Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sunita K Patel
- Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - G William Rebeck
- Department of Neurosciences, Georgetown University School of Medicine, Georgetown University, Washington, DC, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana Alzheimer’s Disease Research Center, and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Harvey Jay Cohen
- Center for the Study of Aging and Human Development, Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA
| | - Jeanne S Mandelblatt
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Judith E Carroll
- UCLA Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
- Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA
| |
Collapse
|
38
|
McDonald BC. Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction. Neurotherapeutics 2021; 18:792-810. [PMID: 34402034 PMCID: PMC8423886 DOI: 10.1007/s13311-021-01096-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/24/2021] [Indexed: 12/13/2022] Open
Abstract
Cancer- and treatment-related cognitive dysfunction (CRCD) is a common challenge faced by patients diagnosed with non-central nervous system (CNS) cancer. It has become increasingly recognized that multiple factors likely play a role in these symptoms, including the cancer disease process, systemic treatments (e.g., chemotherapy and endocrine therapies), and risk factors that may predispose an individual to both cancer and cognitive dysfunction. As the field has evolved, advanced neuroimaging techniques have been applied to better understand the neural correlates of CRCD. This review focuses on structural neuroimaging findings related to CRCD in adult non-CNS cancer populations, including examination of gray matter volume/density and white matter integrity differences between cancer patients and comparison groups, as well as emerging findings regarding structural network abnormalities. Overall, this literature has demonstrated consistent findings of reduced gray matter volume/density and white matter integrity in cancer patients relative to comparison groups. These are most prominent in individuals treated with chemotherapy, though alterations have also been noted in those treated with anti-estrogen and androgen-deprivation therapies. Alterations in gray and white matter structural network connectivity have also been identified. These structural abnormalities have been observed most prominently in frontal and temporal brain regions, and have been shown to correlate with subjective and objective cognitive function, as well as with physiological and clinical variables, helping to inform understanding of CRCD mechanisms. To date, however, structural neuroimaging techniques have not been utilized in systematic studies of potential CRCD treatments, suggesting a potentially fruitful avenue for future research.
Collapse
Affiliation(s)
- Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 355 W. 16th St., GH Suite 4100, Indianapolis, IN, 46202, USA.
| |
Collapse
|
39
|
Mandelblatt JS, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, Extermann M, Graham D, Jacobsen PB, Jim H, McDonald BC, Patel SJ, Root JC, Saykin AJ, Cohen HJ, Carroll JE. Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study. J Natl Cancer Inst 2021; 113:1053-1064. [PMID: 33484565 DOI: 10.1093/jnci/djab003] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 10/27/2020] [Accepted: 01/06/2021] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND We evaluated deficit accumulation and how deficits affected cognition and physical activity among breast cancer survivors and non-cancer controls. METHODS Newly diagnosed nonmetastatic survivors (n = 353) and matched non-cancer controls (n = 355) ages 60-98 years without neurological impairments were assessed presystemic therapy (or at enrollment for controls) from August 2010 to December 2016 and followed for 36 months. Scores on a 42-item index were analyzed in growth-mixture models to determine deficit accumulation trajectories separately and combined for survivors and controls. Multilevel models tested associations between trajectory and cognition (FACT-Cog and neuropsychological tests) and physical activity (IPAQ-SF) for survivors and controls. RESULTS Deficit accumulation scores were in the robust range, but survivors had higher scores (95% confidence intervals [CI]) than controls at 36 months (0.18, 95% CI = 0.16 to 0.19, vs 0.16, 95% CI = 0.14 to 0.17; P = .001), and averages included diverse deficit trajectories. Survivors who were robust but became frailer (8.8%) had similar baseline characteristics to those remaining robust (76.2%) but experienced a 9.6-point decline self-reported cognition (decline of 9.6 vs 3.2 points; P = .04) and a 769 MET minutes per week decline in physical activity (P < .001). Survivors who started and remained prefrail (15.0%) had self-reported and objective cognitive problems. At baseline, frail controls (9.5%) differed from robust controls (83.7%) on deficits and self-reported cognition (P < .001). Within combined trajectories, frail survivors had more sleep disturbances than frail controls (48.6% [SD = 17.4%] vs 25.0% [SD = 8.2%]; P = .05). CONCLUSIONS Most survivors and controls remained robust, and there were similar proportions on a frail trajectory. However, there were differences in deficit patterns between survivors and controls. Survivor deficit accumulation trajectory was associated with patient-reported outcomes. Additional research is needed to understand how breast cancer and its treatments affect deficit accumulation.
Collapse
Affiliation(s)
- Jeanne S Mandelblatt
- Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Tim Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
| | - Martine Extermann
- Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
| | | | - Paul B Jacobsen
- Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Heather Jim
- Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Sunita J Patel
- Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.,Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Harvey Jay Cohen
- Department of Medicine, Duke University School of Medicine, Durham, NC, USA
| | - Judith E Carroll
- UCLA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and Cousins Center for Psychoneuroimmunology, Los Angeles, CA, USA
| |
Collapse
|
40
|
Newhouse PA, Conley AC, Albert K, McDonald BC, Saykin AJ, Dumas J. Cognitive symptoms in early postmenopausal women: Impact on estrogen‐sensitive cholinergic function. Alzheimers Dement 2020. [DOI: 10.1002/alz.044618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Paul A. Newhouse
- Psychiatry, Center for Cognitive Medicine Vanderbilt University Medical Center Nashville TN USA
| | | | | | | | | | | |
Collapse
|
41
|
Risacher SL, Wang S, West JD, Deardorff R, Gao S, McDonald BC, Apostolova LG, Saykin AJ. Influence of rural vs urban county composition on AD neuroimaging biomarkers. Alzheimers Dement 2020. [DOI: 10.1002/alz.046323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Shannon L. Risacher
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Sophia Wang
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Department of Psychiatry Indiana University School of Medicine Indianapolis IN USA
| | - John D. West
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Rachael Deardorff
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Sujuan Gao
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
- Indiana University Center for Aging Research Indianapolis IN USA
| | - Brenna C. McDonald
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Liana G. Apostolova
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Andrew J. Saykin
- Indiana Alzheimer Disease Center Indianapolis IN USA
- Indiana University School of Medicine Indianapolis IN USA
| |
Collapse
|
42
|
Swinford CG, Risacher SL, West JD, Chumin EJ, McDonald BC, Unverzagt FW, Gao S, Farlow MR, Apostolova LG, Wu Y, Brosch JR, Tallman EF, Deardorff R, Kamer AP, Wang DJ, Zetterberg H, Blennow K, Saykin AJ. Plasma tau is negatively correlated with frontal lobe CBF in hypertensive adults on the AD spectrum. Alzheimers Dement 2020. [DOI: 10.1002/alz.046355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
| | | | - John D. West
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | | | | | | | - Sujuan Gao
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | | | | | - Yu‐Chien Wu
- Indiana University School of Medicine Indianapolis IN USA
| | | | | | | | - Aaron P. Kamer
- Indiana University School of Medicine Indianapolis IN USA
| | | | - Henrik Zetterberg
- Institute of Neuroscience and Physiology Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at University of Gothenburg Mölndal Sweden
| | - Kaj Blennow
- Institute of Neuroscience and Physiology University of Gothenburg Mölndal Sweden
| | | |
Collapse
|
43
|
Newhouse PA, Conley AC, Albert K, McDonald BC, Saykin AJ, Boyd B, Kim S, Dumas J. Cognitive symptoms in early postmenopausal women: Relationship to brain structure. Alzheimers Dement 2020. [DOI: 10.1002/alz.044623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Paul A. Newhouse
- Psychiatry, Center for Cognitive Medicine Vanderbilt University Medical Center Nashville TN USA
| | | | | | | | | | - Brian Boyd
- Vanderbilt University Medical Center Nashville TN USA
| | | | | |
Collapse
|
44
|
Price LR, Deardorff R, Wu Y, West JD, McDonald BC, Risacher SL, Saykin AJ. A novel MRI contrast weighted ratio method for measuring myelin in older adults at risk for Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.046297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | | | - Yu‐Chien Wu
- Indiana University School of Medicine Indianapolis IN USA
| | - John D. West
- Indiana University School of Medicine Indianapolis IN USA
| | | | | | | |
Collapse
|
45
|
Chumin EJ, Risacher SL, West JD, Apostolova LG, Farlow MR, McDonald BC, Saykin AJ, Sporns O. Relationships of time‐varying resting state network stability and cognitive function along the Alzheimer’s disease spectrum. Alzheimers Dement 2020. [DOI: 10.1002/alz.040993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Evgeny J. Chumin
- Indiana University Bloomington IN USA
- Indiana University Network Science Institute Bloomington IN USA
| | - Shannon L. Risacher
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - John D. West
- Indiana University School of Medicine Indianapolis IN USA
| | - Liana G. Apostolova
- Indiana University Network Science Institute Bloomington IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Martin R. Farlow
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - Brenna C. McDonald
- Indiana University Network Science Institute Bloomington IN USA
- Indiana University School of Medicine Indianapolis IN USA
- Indiana Alzheimer Disease Center Indianapolis IN USA
| | - Andrew J. Saykin
- Indiana University Network Science Institute Bloomington IN USA
- Indiana University School of Medicine Indianapolis IN USA
| | - Olaf Sporns
- Indiana University Bloomington IN USA
- Indiana University Network Science Institute Bloomington IN USA
| |
Collapse
|
46
|
Conley AC, Albert KM, Boyd BD, Kim SG, Shokouhi S, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA. Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women. Menopause 2020; 27:1220-1227. [PMID: 33110037 PMCID: PMC9153070 DOI: 10.1097/gme.0000000000001613] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE Menopause is associated with increasing cognitive complaints and older women are at increased risk of developing Alzheimer disease compared to men. However, there is difficulty in early markers of risk using objective performance measures. We investigated the impact of subjective cognitive complaints on the cortical structure in a sample of younger postmenopausal women. METHODS Data for this cross-sectional study were drawn from the baseline visit of a longer double-blind study examining estrogen-cholinergic interactions in normal postmenopausal women. Structural Magnetic Resonance Imaging was acquired on 44 women, aged 50-60 years and gray-matter volume was defined by voxel-based morphometry. Subjective measures of cognitive complaints and postmenopausal symptoms were obtained as well as tests of verbal episodic and working memory performance. RESULTS Increased levels of cognitive complaints were associated with lower gray-matter volume in the right medial temporal lobe (r = -0.445, P < 0.002, R = 0.2). Increased depressive symptoms and somatic complaints were also related to increased cognitive complaints and smaller medial temporal volumes but did not mediate the effect of cognitive complaints. In contrast, there was no association between performance on the memory tasks and subjective cognitive ratings, or medial temporal lobe volume. CONCLUSIONS The findings of the present study indicate that the level of reported cognitive complaints in postmenopausal women may be associated with reduced gray-matter volume which may be associated with cortical changes that may increase risk of future cognitive decline. : Video Summary:http://links.lww.com/MENO/A626.
Collapse
Affiliation(s)
- Alexander C. Conley
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
| | - Kimberly M. Albert
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
| | - Brian D. Boyd
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
| | - Shin-Gyeom Kim
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
- Department of Neuropsychiatry, Soonchunhyang University, Bucheon Hospital, Republic of Korea
| | - Sepideh Shokouhi
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
| | - Brenna C. McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN
| | - Andrew J. Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN
| | - Julie A. Dumas
- Clinical Neuroscience Research Unit, Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT
| | - Paul A. Newhouse
- Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN
- Geriatric Research, Education, and Clinical Center, Veterans Affairs Tennessee Valley Health System, Nashville, TN
| |
Collapse
|
47
|
Merz ZC, Flashman LA, Ford JC, McDonald BC, McAllister TW. Comparison of season-long diffusivity measures in a cohort of non-concussed contact and non-contact athletes. J Clin Exp Neuropsychol 2020; 42:811-821. [PMID: 32893734 PMCID: PMC7572734 DOI: 10.1080/13803395.2020.1813257] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Accepted: 08/14/2020] [Indexed: 12/14/2022]
Abstract
INTRODUCTION Concern surrounding short- and long-term consequences of participation in contact sports has become a significant public health topic. Previous literature utilizing diffusion tensor imaging in sports-related concussion has exhibited notable variety of analysis methods and analyzed regions of interest, and largely focuses on acute effects of concussion. The current study aimed to compare diffusivity metrics across a single season within athlete cohorts with no history of concussion. METHODS A prospective cohort of 75 contact and 79 non-contact division I athletes were compared across diffusion tensor imaging metrics (i.e. TRACULA); examinations were also performed assessing the relationship between neuroimaging metrics, head impact exposure metrics (in-helmet accelerometer), and neurocognitive variables. Assessment occurred at pre-and post-season time points. RESULTS Seasonal changes in fractional anisotropy and mean diffusivity values did not differ between athlete cohorts, nor did they differ within cohort groups, across pre- and post-season scans. Specific to contact athletes, positive associations were found between uncinate fasciculus mean diffusivity values and season linear acceleration (p =.018), season rotational acceleration (p =.017), and season hit severity (p =.021). CONCLUSIONS Results suggest an influence of impact frequency, type, and severity on white matter integrity in select brain regions in contact athletes. Current findings expand our knowledge of anatomical changes over the course of a single season, and underscore the importance of considering methodology when interpreting findings in this population, as differing image analysis techniques may lead to different conclusions regarding significant effects.
Collapse
Affiliation(s)
- Zachary C Merz
- LeBauer Department of Neurology, Moses H. Cone Memorial Hospital , Greensboro, NC, USA
| | - Laura A Flashman
- Department of Neurology, Wake Forest Baptist Health, Wake Forest University , Winston-Salem, NC, USA
| | - James C Ford
- Department of Psychiatry, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth , Hanover, NH, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine , Indianapolis, IN, USA
| | - Thomas W McAllister
- Department of Psychiatry, Indiana University School of Medicine , Indianapolis, IN, USA
| |
Collapse
|
48
|
Flashman LA, McDonald BC, Ford JC, Kenny RM, Andrews KD, Saykin AJ, McAllister TW. Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury. J Neurotrauma 2020; 38:225-234. [PMID: 32635808 DOI: 10.1089/neu.2020.7087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Dopamine D1 and D2 receptors differ with respect to patterns of regional brain distribution and behavioral effects. Pre-clinical work suggests that D1 agonists enhance working memory, but the absence of selective D1 agonists has constrained using this approach in humans. This study examines working memory performance in mild traumatic brain injury (mTBI) patients when given pergolide, a mixed D1/D2 agonist, compared with bromocriptine, a selective D2 agonist. Fifteen individuals were studied 1 month after mTBI and compared with 17 healthy controls. At separate visits, participants were administered 1.25 mg bromocriptine or 0.05 mg pergolide prior to functional magnetic resonance imaging (MRI) using a working memory task (visual-verbal n-back). Results indicated a significant group-by-drug interaction for mean performance across n-back task conditions, where the mTBI group showed better performance on pergolide relative to bromocriptine, whereas controls showed the opposite pattern. There was also a significant effect of diagnosis, where mTBI patients performed worse than controls, particularly while on bromocriptine, as shown in our prior work. Functional MRI activation during the most challenging task condition (3-back > 0-back contrast) showed a significant group-by-drug interaction, with the mTBI group showing increased activation relative to controls in working memory circuitry while on pergolide, including in the left inferior frontal gyrus. Across participants there was a positive correlation between change in activation in this region and change in performance between drug conditions. Results suggest that activation of the D1 receptor may improve working memory performance after mTBI. This has implications for the development of pharmacological strategies to treat cognitive deficits after mTBI.
Collapse
Affiliation(s)
- Laura A Flashman
- Department of Neurology, Wake Forest Medical School and Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - James C Ford
- Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
| | - Rachel M Kenny
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Katharine D Andrews
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Thomas W McAllister
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA
| |
Collapse
|
49
|
Kobayashi LC, Cohen HJ, Zhai W, Zhou X, Small BJ, Luta G, Hurria A, Carroll J, Tometich D, McDonald BC, Graham D, Jim HSL, Jacobsen P, Root JC, Saykin AJ, Ahles TA, Mandelblatt J. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study. Psychooncology 2020; 29:1051-1059. [PMID: 32154959 DOI: 10.1002/pon.5376] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2019] [Revised: 01/27/2020] [Accepted: 02/29/2020] [Indexed: 01/08/2023]
Abstract
OBJECTIVE To investigate the relationships between self-reported and objectively measured cognitive function prior to systemic therapy and subsequent well-being outcomes over 24 months in older breast cancer survivors. METHODS Data were from 397 women aged 60 to 98 diagnosed with non-metastatic breast cancer in the Thinking and Living with Cancer Study recruited from 2010-2016. Cognitive function was measured at baseline (following surgery, prior to systemic therapy) using neuropsychological assessments of attention, processing speed, and executive function (APE), learning and memory (LM), and the self-reported FACT-Cog scale. Well-being was measured using the FACT-G functional, physical, social, and emotional well-being domain scales at baseline and 12 and 24 months later, scaled from 0 (low) to 100 (high). Linear mixed-effects models assessed the relationships between each of baseline APE, LM, and FACT-Cog quartiles with well-being scores over 24 months, adjusted for confounding variables. RESULTS At baseline, older survivors in the lowest APE, LM, and FACT-Cog score quartiles experienced poorer global well-being than those in the highest quartiles. At 24 months, older survivors tended to improve in well-being, and there were no differences according to baseline APE or LM scores. At 24 months, mean global well-being was 80.3 (95% CI: 76.2-84.3) among those in the lowest vs 86.6 (95% CI: 83.1-90.1) in the highest FACT-cog quartile, a clinically meaningful difference of 6.3 points (95% CI: 1.5-11.1). CONCLUSIONS Among older breast cancer survivors, self-reported, but not objective cognitive impairments, were associated with lower global well-being over the first 2 years of survivorship.
Collapse
Affiliation(s)
- Lindsay C Kobayashi
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA
| | - Harvey Jay Cohen
- Center for the Study of Aging and Human Development, Duke University, Durham, North Carolina, USA
| | - Wanting Zhai
- Department of Oncology and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Xingtao Zhou
- Department of Oncology and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Brent J Small
- School of Aging Studies, University of South Florida, Tampa, Florida, USA.,Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA
| | - George Luta
- Department of Biostatistics, Bioinformatics, and Biomathematics and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| | - Arti Hurria
- Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
| | - Judith Carroll
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, California, USA
| | - Danielle Tometich
- Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA
| | - Brenna C McDonald
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Deena Graham
- Hackensack University Medical Center, Hackensack, New Jersey, USA
| | - Heather S L Jim
- Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA
| | - Paul Jacobsen
- Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Shady, Maryland, USA
| | - James C Root
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
| | - Andrew J Saykin
- Center for Neuroimaging, Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
| | - Jeanne Mandelblatt
- Department of Oncology and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
| |
Collapse
|
50
|
Mandelblatt JS, Zhai W, Ahn J, Small BJ, Ahles TA, Carroll JE, Denduluri N, Dilawari A, Extermann M, Graham D, Hurria A, Isaacs C, Jacobsen PB, Jim HSL, Luta G, McDonald BC, Patel SK, Root JC, Saykin AJ, Tometich DB, Zhou X, Cohen HJ. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study. Cancer 2019; 126:1183-1192. [PMID: 31860135 DOI: 10.1002/cncr.32663] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Revised: 09/27/2019] [Accepted: 10/15/2019] [Indexed: 12/18/2022]
Abstract
BACKGROUND Little is known about longitudinal symptom burden, its consequences for well-being, and whether lifestyle moderates the burden in older survivors. METHODS The authors report on 36-month data from survivors aged ≥60 years with newly diagnosed, nonmetastatic breast cancer and noncancer controls recruited from August 2010 through June 2016. Symptom burden was measured as the sum of self-reported symptoms/diseases as follows: pain (yes or no), fatigue (on the Functional Assessment of Cancer Therapy [FACT]-Fatigue scale), cognitive (on the FACT-Cognitive scale), sleep problems (yes or no), depression (on the Center for Epidemiologic Studies Depression scale), anxiety (on the State-Trait Anxiety Inventory), and cardiac problems and neuropathy (yes or no). Well-being was measured using the FACT-General scale, with scores from 0 to 100. Lifestyle included smoking, alcohol use, body mass index, physical activity, and leisure activities. Mixed models assessed relations between treatment group (chemotherapy with or without hormone therapy, hormone therapy only, and controls) and symptom burden, lifestyle, and covariates. Separate models tested the effects of fluctuations in symptom burden and lifestyle on function. RESULTS All groups reported high baseline symptoms, and levels remained high over time; differences between survivors and controls were most notable for cognitive and sleep problems, anxiety, and neuropathy. The adjusted burden score was highest among chemotherapy-exposed survivors, followed by hormone therapy-exposed survivors versus controls (P < .001). The burden score was related to physical, emotional, and functional well-being (eg, survivors with lower vs higher burden scores had 12.4-point higher physical well-being scores). The composite lifestyle score was not related to symptom burden or well-being, but physical activity was significantly associated with each outcome (P < .005). CONCLUSIONS Cancer and its treatments are associated with a higher level of actionable symptoms and greater loss of well-being over time in older breast cancer survivors than in comparable noncancer populations, suggesting the need for surveillance and opportunities for intervention.
Collapse
Affiliation(s)
| | - Wanting Zhai
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
| | - Jaeil Ahn
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
| | - Brent J Small
- School of Aging Studies, University of South Florida, and Senior Member, H. Lee Moffitt Cancer Center, Tampa, Florida
| | - Tim A Ahles
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York
| | - Judith E Carroll
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, California
| | | | - Asma Dilawari
- Department of Medicine, Georgetown University, Washington, DC
| | - Martine Extermann
- Department of Medicine, H. Lee Moffitt Cancer Center, Tampa, Florida.,Department and Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida
| | - Deena Graham
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey
| | - Arti Hurria
- Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California
| | - Claudine Isaacs
- Department of Oncology, Georgetown University, Washington, DC.,Department of Medicine, Georgetown University, Washington, DC
| | - Paul B Jacobsen
- Healthcare Delivery Research Program, National Cancer Institute, Bethesda, Maryland
| | - Heather S L Jim
- Health Outcomes and Behavior Department, H. Lee Moffitt Cancer Center, Tampa, Florida
| | - George Luta
- Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
| | - Brenna C McDonald
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana
| | - Sunita K Patel
- Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California.,Department of Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, California
| | - James C Root
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, California
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana
| | - Danielle B Tometich
- Department of Psychology, Indiana University-Purdue University Indianapolis, Indiana
| | - Xingtao Zhou
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC
| | - Harvey J Cohen
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey
| |
Collapse
|